<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/stylesheet.xsl" type="text/xsl"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link rel="self" type="application/rss+xml" href="https://feeds.transistor.fm/labcat-ai-read-alzheimers-disease-paper" title="MP3 Audio"/>
    <atom:link rel="hub" href="https://pubsubhubbub.appspot.com/"/>
    <podcast:podping usesPodping="true"/>
    <title>Labcat.ai Read Alzheimer's Disease Paper</title>
    <generator>Transistor (https://transistor.fm)</generator>
    <itunes:new-feed-url>https://feeds.transistor.fm/labcat-ai-read-alzheimers-disease-paper</itunes:new-feed-url>
    <description>	•	🧠 The best Alzheimer's Disease Paper published yesterday, ranked by impact factor
	•	🏥 Clinical insights and how institutions are responding
	•	💡 Therapeutic innovations and emerging treatment targets
	•	🎯 Practical takeaways for physicians, neurologists, and medical researchers

Get journal's impact factors at : https://www.journalmetrics.org
Find clinical trials easily : https://www.clinicaltrialsfind.com
Find NIH grants trend: https://www.gotgrant.com</description>
    <copyright>© 2026 meng</copyright>
    <podcast:guid>12bbb0a8-e599-59f7-a34a-4af50717550d</podcast:guid>
    <podcast:locked>yes</podcast:locked>
    <language>en</language>
    <pubDate>Sat, 30 May 2026 16:02:32 -0700</pubDate>
    <lastBuildDate>Sat, 30 May 2026 16:03:24 -0700</lastBuildDate>
    <image>
      <url>https://img.transistorcdn.com/9PCxIRsYp3Z2O7qfbanlgMeVuOdCKO6JhK3eDuQrsNs/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMjJm/ZmMxYTk4OWM0ZDlh/ZjY3MWNkMTVkMTM0/NDRjZS5wbmc.jpg</url>
      <title>Labcat.ai Read Alzheimer's Disease Paper</title>
    </image>
    <itunes:category text="Health &amp; Fitness"/>
    <itunes:type>episodic</itunes:type>
    <itunes:author>meng</itunes:author>
    <itunes:image href="https://img.transistorcdn.com/9PCxIRsYp3Z2O7qfbanlgMeVuOdCKO6JhK3eDuQrsNs/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xMjJm/ZmMxYTk4OWM0ZDlh/ZjY3MWNkMTVkMTM0/NDRjZS5wbmc.jpg"/>
    <itunes:summary>	•	🧠 The best Alzheimer's Disease Paper published yesterday, ranked by impact factor
	•	🏥 Clinical insights and how institutions are responding
	•	💡 Therapeutic innovations and emerging treatment targets
	•	🎯 Practical takeaways for physicians, neurologists, and medical researchers

Get journal's impact factors at : https://www.journalmetrics.org
Find clinical trials easily : https://www.clinicaltrialsfind.com
Find NIH grants trend: https://www.gotgrant.com</itunes:summary>
    <itunes:subtitle>	•	🧠 The best Alzheimer's Disease Paper published yesterday, ranked by impact factor
	•	🏥 Clinical insights and how institutions are responding
	•	💡 Therapeutic innovations and emerging treatment targets
	•	🎯 Practical takeaways for physicians, neurologists, and medical researchers

Get journal's impact factors at : https://www.journalmetrics.org
Find clinical trials easily : https://www.clinicaltrialsfind.com
Find NIH grants trend: https://www.gotgrant.com.</itunes:subtitle>
    <itunes:keywords>Alzheimer's Disease</itunes:keywords>
    <itunes:owner>
      <itunes:name>Meng Zhao</itunes:name>
      <itunes:email>nonhelix@gmail.com</itunes:email>
    </itunes:owner>
    <itunes:complete>No</itunes:complete>
    <itunes:explicit>No</itunes:explicit>
    <item>
      <title>May 30, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 30, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">1de46c37-99ce-4f90-a3b9-ad0baacde33b</guid>
      <link>https://share.transistor.fm/s/8c042d33</link>
      <description>
        <![CDATA[May 30, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Treadmill exercise attenuates neuroinflammation in APP/PS1 mice via gut microbiota remodeling: Evidence from fecal microbiota transplantation.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 30, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Treadmill exercise attenuates neuroinflammation in APP/PS1 mice via gut microbiota remodeling: Evidence from fecal microbiota transplantation.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 30 May 2026 16:02:32 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/8c042d33/690bde21.mp3" length="3075264" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>193</itunes:duration>
      <itunes:summary>
        <![CDATA[May 30, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Treadmill exercise attenuates neuroinflammation in APP/PS1 mice via gut microbiota remodeling: Evidence from fecal microbiota transplantation.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 29, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 29, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">03be303a-2a67-4d33-9aba-5de67bafe0f3</guid>
      <link>https://share.transistor.fm/s/42dadb55</link>
      <description>
        <![CDATA[May 29, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Convergent mitochondrial impairment and apoptosis driven by simultaneous down-regulation of multiple genes at 11p11.2 in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 29, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Convergent mitochondrial impairment and apoptosis driven by simultaneous down-regulation of multiple genes at 11p11.2 in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 29 May 2026 16:03:28 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/42dadb55/0450f837.mp3" length="2351232" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>147</itunes:duration>
      <itunes:summary>
        <![CDATA[May 29, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Convergent mitochondrial impairment and apoptosis driven by simultaneous down-regulation of multiple genes at 11p11.2 in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 28, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 28, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0b6956b1-6a0b-4297-b5a3-286b9af577e4</guid>
      <link>https://share.transistor.fm/s/515533ff</link>
      <description>
        <![CDATA[May 28, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Arrhythmias, dementia risk, and neurodegeneration: a cohort study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 28, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Arrhythmias, dementia risk, and neurodegeneration: a cohort study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 28 May 2026 16:03:03 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/515533ff/263c4439.mp3" length="2775744" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>174</itunes:duration>
      <itunes:summary>
        <![CDATA[May 28, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Arrhythmias, dementia risk, and neurodegeneration: a cohort study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 27, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 27, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d19aae18-2e59-441b-a56a-81308625f6b5</guid>
      <link>https://share.transistor.fm/s/344f9aba</link>
      <description>
        <![CDATA[May 27, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Arrhythmias, dementia risk, and neurodegeneration: a cohort study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 27, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Arrhythmias, dementia risk, and neurodegeneration: a cohort study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 27 May 2026 16:02:53 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/344f9aba/f986700e.mp3" length="3123648" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>196</itunes:duration>
      <itunes:summary>
        <![CDATA[May 27, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Arrhythmias, dementia risk, and neurodegeneration: a cohort study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 26, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 26, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7e6d90a2-9076-4d07-bcab-30a707c1d3e8</guid>
      <link>https://share.transistor.fm/s/0dba90ca</link>
      <description>
        <![CDATA[May 26, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 26, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 26 May 2026 16:01:24 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/0dba90ca/a489e408.mp3" length="1317312" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>83</itunes:duration>
      <itunes:summary>
        <![CDATA[May 26, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 25, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 25, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">a226ebb5-e4e6-4c86-a1f9-8228c3a0f5b1</guid>
      <link>https://share.transistor.fm/s/5c7b5b92</link>
      <description>
        <![CDATA[May 25, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degeneration.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 25, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degeneration.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 25 May 2026 16:03:21 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/5c7b5b92/c896b2dd.mp3" length="2200320" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>138</itunes:duration>
      <itunes:summary>
        <![CDATA[May 25, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degeneration.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 24, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 24, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6d98aba0-c750-4872-9350-5b2f39385a09</guid>
      <link>https://share.transistor.fm/s/fb1cec77</link>
      <description>
        <![CDATA[May 24, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Engineered neuronal exosomes mediate α-synuclein clearance to ameliorate Parkinson's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 24, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Engineered neuronal exosomes mediate α-synuclein clearance to ameliorate Parkinson's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 24 May 2026 16:04:16 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/fb1cec77/d3b63355.mp3" length="2884032" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>181</itunes:duration>
      <itunes:summary>
        <![CDATA[May 24, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Engineered neuronal exosomes mediate α-synuclein clearance to ameliorate Parkinson's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 23, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 23, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">50d43f81-730c-4762-af31-4b03fc016066</guid>
      <link>https://share.transistor.fm/s/d02c890a</link>
      <description>
        <![CDATA[May 23, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: CLIS: Causality-inspired Longitudinal Image Synthesis and its application to Alzheimer's disease characterization.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 23, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: CLIS: Causality-inspired Longitudinal Image Synthesis and its application to Alzheimer's disease characterization.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 23 May 2026 16:02:28 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/d02c890a/34ed546c.mp3" length="2587392" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>162</itunes:duration>
      <itunes:summary>
        <![CDATA[May 23, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: CLIS: Causality-inspired Longitudinal Image Synthesis and its application to Alzheimer's disease characterization.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 22, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 22, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">3b23042f-3529-42c5-9910-0a04399a8844</guid>
      <link>https://share.transistor.fm/s/710479c2</link>
      <description>
        <![CDATA[May 22, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 22, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 22 May 2026 16:02:35 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/710479c2/af9cc022.mp3" length="2302848" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>144</itunes:duration>
      <itunes:summary>
        <![CDATA[May 22, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 21, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 21, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ee82bffe-dac3-42df-a050-58a0cf612147</guid>
      <link>https://share.transistor.fm/s/c543db00</link>
      <description>
        <![CDATA[May 21, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 21, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 21 May 2026 16:02:52 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/c543db00/0eaad7e1.mp3" length="2286720" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>143</itunes:duration>
      <itunes:summary>
        <![CDATA[May 21, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Illuminating proinflammatory myeloid cells with PET tracers targeting GPR84.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 20, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 20, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">372f00dd-9541-476e-ab4d-81afd7fe7cb6</guid>
      <link>https://share.transistor.fm/s/1c99e7f1</link>
      <description>
        <![CDATA[May 20, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Bibliometric analysis of nanomaterials in the diagnosis and treatment of neurological and psychiatric disorders (1997-2025): trends and future directions.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 20, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Bibliometric analysis of nanomaterials in the diagnosis and treatment of neurological and psychiatric disorders (1997-2025): trends and future directions.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 20 May 2026 16:02:02 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/1c99e7f1/63c14d1d.mp3" length="2174400" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>136</itunes:duration>
      <itunes:summary>
        <![CDATA[May 20, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Bibliometric analysis of nanomaterials in the diagnosis and treatment of neurological and psychiatric disorders (1997-2025): trends and future directions.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 19, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 19, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">fd4188b0-48ce-4105-8fbd-c90e4d5bdbc0</guid>
      <link>https://share.transistor.fm/s/ed4541a7</link>
      <description>
        <![CDATA[May 19, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Bibliometric analysis of nanomaterials in the diagnosis and treatment of neurological and psychiatric disorders (1997-2025): trends and future directions.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 19, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Bibliometric analysis of nanomaterials in the diagnosis and treatment of neurological and psychiatric disorders (1997-2025): trends and future directions.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 19 May 2026 16:01:28 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/ed4541a7/5727461f.mp3" length="1779840" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>112</itunes:duration>
      <itunes:summary>
        <![CDATA[May 19, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Bibliometric analysis of nanomaterials in the diagnosis and treatment of neurological and psychiatric disorders (1997-2025): trends and future directions.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 18, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 18, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">dc836448-d769-4321-9bf9-776bf3c9a916</guid>
      <link>https://share.transistor.fm/s/6271b37f</link>
      <description>
        <![CDATA[May 18, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Multi-target Triazole-Benzopyrone hybrids modulating cholinergic dysfunction, oxidative stress, and neuroinflammation through GFAP/NF-κB/APOE/NLRP3 axis in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 18, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Multi-target Triazole-Benzopyrone hybrids modulating cholinergic dysfunction, oxidative stress, and neuroinflammation through GFAP/NF-κB/APOE/NLRP3 axis in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 18 May 2026 16:01:14 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/6271b37f/7898ec24.mp3" length="2277504" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>143</itunes:duration>
      <itunes:summary>
        <![CDATA[May 18, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Multi-target Triazole-Benzopyrone hybrids modulating cholinergic dysfunction, oxidative stress, and neuroinflammation through GFAP/NF-κB/APOE/NLRP3 axis in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 17, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 17, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">5acdbb34-ce5a-41be-9b4b-bf285e30bf1f</guid>
      <link>https://share.transistor.fm/s/688e2fce</link>
      <description>
        <![CDATA[May 17, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 17, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 17 May 2026 16:01:31 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/688e2fce/f2f745db.mp3" length="1605312" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>101</itunes:duration>
      <itunes:summary>
        <![CDATA[May 17, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 16, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 16, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">281d8121-4622-4f84-9a22-1e71543d89bb</guid>
      <link>https://share.transistor.fm/s/87570320</link>
      <description>
        <![CDATA[May 16, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 16, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 16 May 2026 16:01:35 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/87570320/090d1b42.mp3" length="1260288" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>79</itunes:duration>
      <itunes:summary>
        <![CDATA[May 16, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 15, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 15, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">84007dc1-edfd-4372-a4f0-7a461afe05e7</guid>
      <link>https://share.transistor.fm/s/f18d4b39</link>
      <description>
        <![CDATA[May 15, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 15, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 15 May 2026 16:01:03 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/f18d4b39/645bd035.mp3" length="1028160" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>65</itunes:duration>
      <itunes:summary>
        <![CDATA[May 15, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 14, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 14, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c0ee5dec-0446-4fd5-8f03-a1dac6683bf0</guid>
      <link>https://share.transistor.fm/s/120bfa41</link>
      <description>
        <![CDATA[May 14, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 14, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 14 May 2026 16:01:51 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/120bfa41/b35c40b8.mp3" length="1980864" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>124</itunes:duration>
      <itunes:summary>
        <![CDATA[May 14, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 13, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 13, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">5d70a76c-fd7b-43ca-8595-185d05839470</guid>
      <link>https://share.transistor.fm/s/ef7bbd3b</link>
      <description>
        <![CDATA[May 13, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Blood biomarkers of Alzheimer's disease and 15-year decline in cognitive and motor functions in older adults.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 13, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Blood biomarkers of Alzheimer's disease and 15-year decline in cognitive and motor functions in older adults.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 13 May 2026 16:03:57 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/ef7bbd3b/d27b2819.mp3" length="2575296" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>161</itunes:duration>
      <itunes:summary>
        <![CDATA[May 13, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Blood biomarkers of Alzheimer's disease and 15-year decline in cognitive and motor functions in older adults.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 12, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 12, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b7296a74-c740-4106-a084-40ae7ba8fed2</guid>
      <link>https://share.transistor.fm/s/59779067</link>
      <description>
        <![CDATA[May 12, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Advances in Modeling Memory Decline: A Critical Overview of Current Animal and Human Paradigms.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 12, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Advances in Modeling Memory Decline: A Critical Overview of Current Animal and Human Paradigms.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 12 May 2026 16:01:58 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/59779067/0c486198.mp3" length="2209536" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>139</itunes:duration>
      <itunes:summary>
        <![CDATA[May 12, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Advances in Modeling Memory Decline: A Critical Overview of Current Animal and Human Paradigms.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 11, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 11, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">8769d6cf-dc80-4a74-a286-5098932b46f9</guid>
      <link>https://share.transistor.fm/s/67e7516f</link>
      <description>
        <![CDATA[May 11, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Alzheimer's Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 11, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Alzheimer's Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 11 May 2026 16:02:19 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/67e7516f/8e38c446.mp3" length="1823616" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>114</itunes:duration>
      <itunes:summary>
        <![CDATA[May 11, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Alzheimer's Disease Co-Pathology and Cognitive Impairment in Amyotrophic Lateral Sclerosis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 10, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 10, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">95d49fa0-4e9c-40e8-a025-23eacc81807e</guid>
      <link>https://share.transistor.fm/s/745afc4a</link>
      <description>
        <![CDATA[May 10, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Urolithin A: potential to enhance autophagic clearance and mitigate neuroinflammation in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 10, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Urolithin A: potential to enhance autophagic clearance and mitigate neuroinflammation in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 10 May 2026 16:05:02 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/745afc4a/d4256a58.mp3" length="2460672" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>154</itunes:duration>
      <itunes:summary>
        <![CDATA[May 10, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Urolithin A: potential to enhance autophagic clearance and mitigate neuroinflammation in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 09, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 09, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d71655a6-c9b4-4da9-baef-319ed9579d21</guid>
      <link>https://share.transistor.fm/s/d563400d</link>
      <description>
        <![CDATA[May 09, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: From senescence and inflammaging to systemic comorbidities: Drivers of aging-associated periodontitis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 09, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: From senescence and inflammaging to systemic comorbidities: Drivers of aging-associated periodontitis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 09 May 2026 16:05:24 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/d563400d/3dd5d39c.mp3" length="2438784" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>153</itunes:duration>
      <itunes:summary>
        <![CDATA[May 09, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: From senescence and inflammaging to systemic comorbidities: Drivers of aging-associated periodontitis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 08, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 08, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7fddb6e8-fea0-408e-aab6-1cabc2a7d851</guid>
      <link>https://share.transistor.fm/s/9edcb6f5</link>
      <description>
        <![CDATA[May 08, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: From senescence and inflammaging to systemic comorbidities: Drivers of aging-associated periodontitis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 08, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: From senescence and inflammaging to systemic comorbidities: Drivers of aging-associated periodontitis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 08 May 2026 16:04:52 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/9edcb6f5/80bd6981.mp3" length="2221056" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>139</itunes:duration>
      <itunes:summary>
        <![CDATA[May 08, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: From senescence and inflammaging to systemic comorbidities: Drivers of aging-associated periodontitis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 07, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 07, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ee390666-1901-4600-8d12-ae7f2dde5396</guid>
      <link>https://share.transistor.fm/s/61c2b831</link>
      <description>
        <![CDATA[May 07, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: BundleWarp: Enhancing white matter tractometry and morphometry with precise neuronal mapping using streamline-based nonlinear registration.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 07, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: BundleWarp: Enhancing white matter tractometry and morphometry with precise neuronal mapping using streamline-based nonlinear registration.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 07 May 2026 16:05:50 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/61c2b831/cd114525.mp3" length="2378880" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>149</itunes:duration>
      <itunes:summary>
        <![CDATA[May 07, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: BundleWarp: Enhancing white matter tractometry and morphometry with precise neuronal mapping using streamline-based nonlinear registration.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 06, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 06, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0026fb4b-821c-45c3-a16e-3c44ea250ff1</guid>
      <link>https://share.transistor.fm/s/37f2300e</link>
      <description>
        <![CDATA[May 06, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: E(2)AD: Enhanced and explainable Alzheimer's disease detection framework via anatomy- and relation-aware cross-modal knowledge distillation.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 06, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: E(2)AD: Enhanced and explainable Alzheimer's disease detection framework via anatomy- and relation-aware cross-modal knowledge distillation.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 06 May 2026 16:04:00 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/37f2300e/7e5bd8a9.mp3" length="2325888" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>146</itunes:duration>
      <itunes:summary>
        <![CDATA[May 06, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: E(2)AD: Enhanced and explainable Alzheimer's disease detection framework via anatomy- and relation-aware cross-modal knowledge distillation.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 05, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 05, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">66d20697-5bf7-422e-96bc-5b84a5d99eaf</guid>
      <link>https://share.transistor.fm/s/91e4488e</link>
      <description>
        <![CDATA[May 05, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Multimorbidity and Associations with Cognition and Alzheimer's Disease Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 05, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Multimorbidity and Associations with Cognition and Alzheimer's Disease Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 05 May 2026 16:07:03 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/91e4488e/8b0ab1ab.mp3" length="2294208" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>144</itunes:duration>
      <itunes:summary>
        <![CDATA[May 05, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Multimorbidity and Associations with Cognition and Alzheimer's Disease Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 04, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 04, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7f7149b1-356a-4740-af6d-8726dd7e3310</guid>
      <link>https://share.transistor.fm/s/a9b1b724</link>
      <description>
        <![CDATA[May 04, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 04, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 04 May 2026 16:02:04 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/a9b1b724/d6335627.mp3" length="1626624" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>102</itunes:duration>
      <itunes:summary>
        <![CDATA[May 04, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 02, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 02, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">aad2397e-8945-40cf-b64a-e068eab8a125</guid>
      <link>https://share.transistor.fm/s/1ba674c1</link>
      <description>
        <![CDATA[May 02, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Multi-ancestry transcriptome-wide association study reveals shared and population-specific genetic effects in Alzheimer disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 02, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Multi-ancestry transcriptome-wide association study reveals shared and population-specific genetic effects in Alzheimer disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 02 May 2026 16:02:17 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/1ba674c1/7f82e13b.mp3" length="2953728" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>185</itunes:duration>
      <itunes:summary>
        <![CDATA[May 02, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Multi-ancestry transcriptome-wide association study reveals shared and population-specific genetic effects in Alzheimer disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 01, 2026 - Alzheimer Research Update</title>
      <itunes:title>May 01, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">05b87c67-94e9-4b14-8060-e89199e47261</guid>
      <link>https://share.transistor.fm/s/9be75c3f</link>
      <description>
        <![CDATA[May 01, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Characterizing the metabolomes of microglia, astrocytes and neurons in ageing and Alzheimer's brains.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 01, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Characterizing the metabolomes of microglia, astrocytes and neurons in ageing and Alzheimer's brains.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 01 May 2026 16:02:51 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/9be75c3f/42a1cebd.mp3" length="1846656" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>116</itunes:duration>
      <itunes:summary>
        <![CDATA[May 01, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Characterizing the metabolomes of microglia, astrocytes and neurons in ageing and Alzheimer's brains.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>April 30, 2026 - Alzheimer Research Update</title>
      <itunes:title>April 30, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">f8cc997c-5ef6-46f5-b099-83b6e88aa50d</guid>
      <link>https://share.transistor.fm/s/88bc1a3a</link>
      <description>
        <![CDATA[April 30, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Serious Side Effects of Alzheimer's Immunotherapy Demand Scrutiny.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[April 30, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Serious Side Effects of Alzheimer's Immunotherapy Demand Scrutiny.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 30 Apr 2026 16:04:08 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/88bc1a3a/90cd4f01.mp3" length="1770624" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>111</itunes:duration>
      <itunes:summary>
        <![CDATA[April 30, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Serious Side Effects of Alzheimer's Immunotherapy Demand Scrutiny.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>April 29, 2026 - Alzheimer Research Update</title>
      <itunes:title>April 29, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">65c15c0d-964e-40e8-a3ef-43683631c568</guid>
      <link>https://share.transistor.fm/s/ae3091ea</link>
      <description>
        <![CDATA[April 29, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: RETRACTION: The 12-15-Lipoxygenase is a Modulator of Alzheimer's-Related Tau Pathology In Vivo.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[April 29, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: RETRACTION: The 12-15-Lipoxygenase is a Modulator of Alzheimer's-Related Tau Pathology In Vivo.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 29 Apr 2026 16:03:11 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/ae3091ea/0cb06db0.mp3" length="110592" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>7</itunes:duration>
      <itunes:summary>
        <![CDATA[April 29, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: RETRACTION: The 12-15-Lipoxygenase is a Modulator of Alzheimer's-Related Tau Pathology In Vivo.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>April 28, 2026 - Alzheimer Research Update</title>
      <itunes:title>April 28, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">33d964f1-7dd2-4139-af9a-827428c569bb</guid>
      <link>https://share.transistor.fm/s/2ead6508</link>
      <description>
        <![CDATA[April 28, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Mitochondrial-nuclear crosstalk: A central axis in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[April 28, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Mitochondrial-nuclear crosstalk: A central axis in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 28 Apr 2026 16:03:14 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/2ead6508/5cb9faaf.mp3" length="1988928" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>125</itunes:duration>
      <itunes:summary>
        <![CDATA[April 28, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Mitochondrial-nuclear crosstalk: A central axis in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>April 27, 2026 - Alzheimer Research Update</title>
      <itunes:title>April 27, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">a0200e7d-4713-4c23-842c-8410e6db84df</guid>
      <link>https://share.transistor.fm/s/c662b897</link>
      <description>
        <![CDATA[April 27, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Signaling Pathways Triggering Therapeutical Potential of Marine-Derived Polysaccharides in Alzheimer's Disease: A Recent Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[April 27, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Signaling Pathways Triggering Therapeutical Potential of Marine-Derived Polysaccharides in Alzheimer's Disease: A Recent Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 27 Apr 2026 16:06:37 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/c662b897/f45abdbd.mp3" length="3624768" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>227</itunes:duration>
      <itunes:summary>
        <![CDATA[April 27, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Signaling Pathways Triggering Therapeutical Potential of Marine-Derived Polysaccharides in Alzheimer's Disease: A Recent Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>April 26, 2026 - Alzheimer Research Update</title>
      <itunes:title>April 26, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">269c9f9a-548b-408e-baa3-6b24a2c4c5dc</guid>
      <link>https://share.transistor.fm/s/a8ad11d3</link>
      <description>
        <![CDATA[April 26, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Myokine Irisin Represents an Indirect Pathway Linking Exercise to Hippocampal Subfields Relevant to Alzheimer's Disease and Neurogenesis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[April 26, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Myokine Irisin Represents an Indirect Pathway Linking Exercise to Hippocampal Subfields Relevant to Alzheimer's Disease and Neurogenesis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 26 Apr 2026 16:08:42 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/a8ad11d3/60fe4ed2.mp3" length="2397888" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>150</itunes:duration>
      <itunes:summary>
        <![CDATA[April 26, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Myokine Irisin Represents an Indirect Pathway Linking Exercise to Hippocampal Subfields Relevant to Alzheimer's Disease and Neurogenesis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>April 25, 2026 - Alzheimer Research Update</title>
      <itunes:title>April 25, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">daff4f65-fa82-4769-b4f7-45ee585b0c41</guid>
      <link>https://share.transistor.fm/s/d63e7826</link>
      <description>
        <![CDATA[April 25, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Co-Aggregation of Amyloidogenic Proteins in Age-Related Neurodegenerative Diseases.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[April 25, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Co-Aggregation of Amyloidogenic Proteins in Age-Related Neurodegenerative Diseases.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 25 Apr 2026 16:05:49 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/d63e7826/7f91deae.mp3" length="2786688" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>175</itunes:duration>
      <itunes:summary>
        <![CDATA[April 25, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Co-Aggregation of Amyloidogenic Proteins in Age-Related Neurodegenerative Diseases.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>April 24, 2026 - Alzheimer Research Update</title>
      <itunes:title>April 24, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">38c8b73a-0b85-450b-b42b-a1cc79224712</guid>
      <link>https://share.transistor.fm/s/afb8d8bd</link>
      <description>
        <![CDATA[April 24, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Targeting Mitochondrial Quality Control in Alzheimer's Disease: Mechanisms and Therapeutic Potential of Phytomedicines.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[April 24, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Targeting Mitochondrial Quality Control in Alzheimer's Disease: Mechanisms and Therapeutic Potential of Phytomedicines.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 24 Apr 2026 16:03:04 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/afb8d8bd/1ce52e3a.mp3" length="2070144" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>130</itunes:duration>
      <itunes:summary>
        <![CDATA[April 24, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Targeting Mitochondrial Quality Control in Alzheimer's Disease: Mechanisms and Therapeutic Potential of Phytomedicines.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>April 23, 2026 - Alzheimer Research Update</title>
      <itunes:title>April 23, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">440d9e04-b55e-414b-80cc-5110d2d4ada6</guid>
      <link>https://share.transistor.fm/s/e5c72beb</link>
      <description>
        <![CDATA[April 23, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Comorbid Alzheimer's Disease and Type 2 Diabetes Microbiota Shape Age-Associated Gut-Brain Axis Profiles.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[April 23, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Comorbid Alzheimer's Disease and Type 2 Diabetes Microbiota Shape Age-Associated Gut-Brain Axis Profiles.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 23 Apr 2026 16:03:56 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/e5c72beb/eb5df5e8.mp3" length="2189376" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>137</itunes:duration>
      <itunes:summary>
        <![CDATA[April 23, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Comorbid Alzheimer's Disease and Type 2 Diabetes Microbiota Shape Age-Associated Gut-Brain Axis Profiles.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 27, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 27, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b340945e-4296-4908-a2d4-c0363e9e20a6</guid>
      <link>https://share.transistor.fm/s/69e6db24</link>
      <description>
        <![CDATA[January 27, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Exploratory RNA Sequencing Reveals Systemic Metabolic Dysregulation in Alzheimer's Disease: Insights from a Diverse Latin American Cohort.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 27, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Exploratory RNA Sequencing Reveals Systemic Metabolic Dysregulation in Alzheimer's Disease: Insights from a Diverse Latin American Cohort.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 27 Jan 2026 15:05:57 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/69e6db24/073b5734.mp3" length="2469312" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>155</itunes:duration>
      <itunes:summary>
        <![CDATA[January 27, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Exploratory RNA Sequencing Reveals Systemic Metabolic Dysregulation in Alzheimer's Disease: Insights from a Diverse Latin American Cohort.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 26, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 26, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">8bfae168-1e3e-46ea-a8e8-74996b863ec0</guid>
      <link>https://share.transistor.fm/s/3839d90f</link>
      <description>
        <![CDATA[January 26, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Age-associated increases in PAI-1 silenced with siRNA-lipid nanoparticles reduces thrombosis and prolongs lifespan.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 26, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Age-associated increases in PAI-1 silenced with siRNA-lipid nanoparticles reduces thrombosis and prolongs lifespan.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 26 Jan 2026 15:04:40 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/3839d90f/4d8b3b52.mp3" length="2075904" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>130</itunes:duration>
      <itunes:summary>
        <![CDATA[January 26, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Age-associated increases in PAI-1 silenced with siRNA-lipid nanoparticles reduces thrombosis and prolongs lifespan.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 25, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 25, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">52b2c9d7-f9cc-4f82-a9fe-4d4ee4448846</guid>
      <link>https://share.transistor.fm/s/1df7f85f</link>
      <description>
        <![CDATA[January 25, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Hippocampal surface morphological variation-based genome-wide association analysis network for biomarker detection of Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 25, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Hippocampal surface morphological variation-based genome-wide association analysis network for biomarker detection of Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 25 Jan 2026 15:06:00 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/1df7f85f/e8f7bc11.mp3" length="2310912" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>145</itunes:duration>
      <itunes:summary>
        <![CDATA[January 25, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Hippocampal surface morphological variation-based genome-wide association analysis network for biomarker detection of Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 24, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 24, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">461f9890-2a95-4d6a-8d5a-f934b40e1521</guid>
      <link>https://share.transistor.fm/s/7021eafd</link>
      <description>
        <![CDATA[January 24, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Early synaptic pathology is associated with small tau aggregates in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 24, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Early synaptic pathology is associated with small tau aggregates in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 24 Jan 2026 15:05:36 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/7021eafd/174304ab.mp3" length="2621376" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>164</itunes:duration>
      <itunes:summary>
        <![CDATA[January 24, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Early synaptic pathology is associated with small tau aggregates in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 23, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 23, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b3982d0a-4d77-4396-bf3f-5cdb2e44feaf</guid>
      <link>https://share.transistor.fm/s/a3e74894</link>
      <description>
        <![CDATA[January 23, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Early synaptic pathology is associated with small tau aggregates in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 23, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Early synaptic pathology is associated with small tau aggregates in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 23 Jan 2026 15:07:05 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/a3e74894/3821f7fe.mp3" length="2634048" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>165</itunes:duration>
      <itunes:summary>
        <![CDATA[January 23, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Early synaptic pathology is associated with small tau aggregates in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 22, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 22, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">cc1b2bf6-780a-4b7a-bea1-c7a7127f8484</guid>
      <link>https://share.transistor.fm/s/478278eb</link>
      <description>
        <![CDATA[January 22, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Evaluating Senescence-Targeted Approaches in Alzheimer's Disease: What We Know and What Lies Ahead.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 22, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Evaluating Senescence-Targeted Approaches in Alzheimer's Disease: What We Know and What Lies Ahead.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 22 Jan 2026 15:05:17 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/478278eb/92bdd04f.mp3" length="2475072" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>155</itunes:duration>
      <itunes:summary>
        <![CDATA[January 22, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Evaluating Senescence-Targeted Approaches in Alzheimer's Disease: What We Know and What Lies Ahead.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 21, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 21, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">3f828bcd-3898-4dcd-b9f8-5f4aa459d6ae</guid>
      <link>https://share.transistor.fm/s/7b5e12d6</link>
      <description>
        <![CDATA[January 21, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Impact of Textile-Derived Micro- and Nanoplastics on Brain Health: An Emerging Environmental Risk.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 21, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Impact of Textile-Derived Micro- and Nanoplastics on Brain Health: An Emerging Environmental Risk.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 21 Jan 2026 15:05:24 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/7b5e12d6/1c6b5b7e.mp3" length="113472" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[January 21, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Impact of Textile-Derived Micro- and Nanoplastics on Brain Health: An Emerging Environmental Risk.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 20, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 20, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">da37b703-6427-494d-aa2e-f06d829e38e8</guid>
      <link>https://share.transistor.fm/s/76ca1b3c</link>
      <description>
        <![CDATA[January 20, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Ferroptosis in neurological diseases: moving towards therapeutic intervention.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 20, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Ferroptosis in neurological diseases: moving towards therapeutic intervention.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 20 Jan 2026 15:04:19 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/76ca1b3c/9a98f48e.mp3" length="1738368" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>109</itunes:duration>
      <itunes:summary>
        <![CDATA[January 20, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Ferroptosis in neurological diseases: moving towards therapeutic intervention.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 19, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 19, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">40b3e217-ea48-4f75-8048-941dedc631d1</guid>
      <link>https://share.transistor.fm/s/852169ac</link>
      <description>
        <![CDATA[January 19, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Decoding synaptic imbalance in neurodegenerative diseases: From pathological analysis to targeted intervention.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 19, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Decoding synaptic imbalance in neurodegenerative diseases: From pathological analysis to targeted intervention.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 19 Jan 2026 15:04:57 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/852169ac/4dd7735e.mp3" length="1762560" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>111</itunes:duration>
      <itunes:summary>
        <![CDATA[January 19, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Decoding synaptic imbalance in neurodegenerative diseases: From pathological analysis to targeted intervention.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 18, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 18, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ac837fc0-c1a6-4a81-9c7d-2112b6c9ca6f</guid>
      <link>https://share.transistor.fm/s/928e6620</link>
      <description>
        <![CDATA[January 18, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Single-vesicle profiling of multiple biomarkers on serum EVs via EV-CATCH and nano-flow cytometry for clinical stratification of Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 18, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Single-vesicle profiling of multiple biomarkers on serum EVs via EV-CATCH and nano-flow cytometry for clinical stratification of Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 18 Jan 2026 15:03:57 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/928e6620/35f19abd.mp3" length="115200" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[January 18, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Single-vesicle profiling of multiple biomarkers on serum EVs via EV-CATCH and nano-flow cytometry for clinical stratification of Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 17, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 17, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">5b423526-8422-46c8-8963-73639a09e501</guid>
      <link>https://share.transistor.fm/s/df1f63bf</link>
      <description>
        <![CDATA[January 17, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Interaction effects of extreme temperature events and air pollutants on neurodegenerative disease mortality: A case-crossover study in a cold-winter, hot-summer region of China.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 17, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Interaction effects of extreme temperature events and air pollutants on neurodegenerative disease mortality: A case-crossover study in a cold-winter, hot-summer region of China.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 17 Jan 2026 15:03:42 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/df1f63bf/44d12f07.mp3" length="2204352" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>138</itunes:duration>
      <itunes:summary>
        <![CDATA[January 17, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Interaction effects of extreme temperature events and air pollutants on neurodegenerative disease mortality: A case-crossover study in a cold-winter, hot-summer region of China.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 16, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 16, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e14c1141-bccd-4699-a2f3-694c1f3fa9a9</guid>
      <link>https://share.transistor.fm/s/5bffe226</link>
      <description>
        <![CDATA[January 16, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Circulating C-reactive protein influences polygenic risk of inflammatory genes expressed in brain endothelia for Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 16, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Circulating C-reactive protein influences polygenic risk of inflammatory genes expressed in brain endothelia for Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 16 Jan 2026 15:03:47 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/5bffe226/5e5207a3.mp3" length="2093760" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>131</itunes:duration>
      <itunes:summary>
        <![CDATA[January 16, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Circulating C-reactive protein influences polygenic risk of inflammatory genes expressed in brain endothelia for Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 14, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 14, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6d391cd4-5d01-4a91-b639-1841267f5a18</guid>
      <link>https://share.transistor.fm/s/226e6f47</link>
      <description>
        <![CDATA[January 14, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Adjacent-aware Modality Recovery based on Incomplete Multi-Modal Brain Disease Diagnosis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 14, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Adjacent-aware Modality Recovery based on Incomplete Multi-Modal Brain Disease Diagnosis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 14 Jan 2026 15:03:03 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/226e6f47/7611b09b.mp3" length="2427840" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>152</itunes:duration>
      <itunes:summary>
        <![CDATA[January 14, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Adjacent-aware Modality Recovery based on Incomplete Multi-Modal Brain Disease Diagnosis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 12, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 12, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">4183ee8a-bbb4-4de9-8e88-fb274b6db8df</guid>
      <link>https://share.transistor.fm/s/809f976e</link>
      <description>
        <![CDATA[January 12, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Carrier-free nanoassembly with dual antioxidant and anti-inflammatory activities camouflaged by melanoma cell membrane for tau-targeted therapy of Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 12, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Carrier-free nanoassembly with dual antioxidant and anti-inflammatory activities camouflaged by melanoma cell membrane for tau-targeted therapy of Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 12 Jan 2026 15:04:26 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/809f976e/3384742a.mp3" length="2481984" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>156</itunes:duration>
      <itunes:summary>
        <![CDATA[January 12, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Carrier-free nanoassembly with dual antioxidant and anti-inflammatory activities camouflaged by melanoma cell membrane for tau-targeted therapy of Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 11, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 11, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">8e0d7eb3-d337-44eb-8c67-7d8cd63e8d0a</guid>
      <link>https://share.transistor.fm/s/80973608</link>
      <description>
        <![CDATA[January 11, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 11, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 11 Jan 2026 15:03:32 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/80973608/4e2ae3d9.mp3" length="115200" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[January 11, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 10, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 10, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">afd553e6-7b33-4b81-bfa9-124d33d70eed</guid>
      <link>https://share.transistor.fm/s/49735dd4</link>
      <description>
        <![CDATA[January 10, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 10, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 10 Jan 2026 15:06:12 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/49735dd4/f438d3f0.mp3" length="115200" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[January 10, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 09, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 09, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">aade458c-96cc-4db1-a6bd-dff1a53e98f1</guid>
      <link>https://share.transistor.fm/s/6c089f53</link>
      <description>
        <![CDATA[January 09, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenias of Undetermined Significance: 2026 Update on Clinical Associations and Management Recommendations.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 09, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenias of Undetermined Significance: 2026 Update on Clinical Associations and Management Recommendations.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 09 Jan 2026 15:04:01 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/6c089f53/c9fb7a16.mp3" length="2703744" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>169</itunes:duration>
      <itunes:summary>
        <![CDATA[January 09, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Clonal Hematopoiesis of Indeterminate Potential and Clonal Cytopenias of Undetermined Significance: 2026 Update on Clinical Associations and Management Recommendations.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 08, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 08, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">219aa051-fd76-410b-901d-41bc8b9ed8f9</guid>
      <link>https://share.transistor.fm/s/2adf30e8</link>
      <description>
        <![CDATA[January 08, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Vascular Cognitive Impairment and Dementia: Clinical Features, Neuropathology, and Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 08, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Vascular Cognitive Impairment and Dementia: Clinical Features, Neuropathology, and Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 08 Jan 2026 15:02:46 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/2adf30e8/decf887b.mp3" length="2299392" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>144</itunes:duration>
      <itunes:summary>
        <![CDATA[January 08, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Vascular Cognitive Impairment and Dementia: Clinical Features, Neuropathology, and Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 07, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 07, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b42164cc-d499-4d25-8cfd-124eaab25823</guid>
      <link>https://share.transistor.fm/s/981a5e6f</link>
      <description>
        <![CDATA[January 07, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Vascular Cognitive Impairment and Dementia: Clinical Features, Neuropathology, and Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 07, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Vascular Cognitive Impairment and Dementia: Clinical Features, Neuropathology, and Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 07 Jan 2026 15:03:04 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/981a5e6f/b91f163f.mp3" length="2544192" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>160</itunes:duration>
      <itunes:summary>
        <![CDATA[January 07, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Vascular Cognitive Impairment and Dementia: Clinical Features, Neuropathology, and Biomarkers.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 06, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 06, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">826b1b82-7973-4527-988e-b50d528a6762</guid>
      <link>https://share.transistor.fm/s/2965b4b4</link>
      <description>
        <![CDATA[January 06, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 06, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 06 Jan 2026 15:03:26 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/2965b4b4/f9d9eb03.mp3" length="2164032" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>136</itunes:duration>
      <itunes:summary>
        <![CDATA[January 06, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: A minimally invasive dried blood spot biomarker test for the detection of Alzheimer's disease pathology.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 05, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 05, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">42723c9e-baeb-4c75-b48b-faa7dc276bd6</guid>
      <link>https://share.transistor.fm/s/8cf28e09</link>
      <description>
        <![CDATA[January 05, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: GASDERMIN D-mediated pyroptosis as a therapeutic target in TAU-dependent frontotemporal dementia mouse model.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 05, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: GASDERMIN D-mediated pyroptosis as a therapeutic target in TAU-dependent frontotemporal dementia mouse model.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 05 Jan 2026 15:05:57 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/8cf28e09/59424e75.mp3" length="2462976" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>154</itunes:duration>
      <itunes:summary>
        <![CDATA[January 05, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: GASDERMIN D-mediated pyroptosis as a therapeutic target in TAU-dependent frontotemporal dementia mouse model.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 04, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 04, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">fc6b9a6e-6bd1-4a83-9e77-ec759f21e914</guid>
      <link>https://share.transistor.fm/s/433ace6a</link>
      <description>
        <![CDATA[January 04, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Structure of pancreatic hIAPP fibrils derived from patients with type 2 diabetes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 04, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Structure of pancreatic hIAPP fibrils derived from patients with type 2 diabetes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 04 Jan 2026 15:05:17 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/433ace6a/15b408eb.mp3" length="1975680" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>124</itunes:duration>
      <itunes:summary>
        <![CDATA[January 04, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Structure of pancreatic hIAPP fibrils derived from patients with type 2 diabetes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 03, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 03, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">a147d4d9-083b-474c-b88a-b0c9c9dcb00d</guid>
      <link>https://share.transistor.fm/s/2acc59f4</link>
      <description>
        <![CDATA[January 03, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: cGAS-STING signaling in Alzheimer's disease: Microglial mechanisms and therapeutic opportunities.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 03, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: cGAS-STING signaling in Alzheimer's disease: Microglial mechanisms and therapeutic opportunities.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 03 Jan 2026 15:04:22 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/2acc59f4/17ec481a.mp3" length="2013696" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>126</itunes:duration>
      <itunes:summary>
        <![CDATA[January 03, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: cGAS-STING signaling in Alzheimer's disease: Microglial mechanisms and therapeutic opportunities.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 02, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 02, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">1851e691-2335-4a75-b21f-c50da28b0d3f</guid>
      <link>https://share.transistor.fm/s/a32e2556</link>
      <description>
        <![CDATA[January 02, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Therapeutic application of fecal microbiota transplantation for neurological diseases: Exploring novel mechanisms and perspectives.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 02, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Therapeutic application of fecal microbiota transplantation for neurological diseases: Exploring novel mechanisms and perspectives.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 02 Jan 2026 15:03:52 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/a32e2556/598f918b.mp3" length="264960" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>17</itunes:duration>
      <itunes:summary>
        <![CDATA[January 02, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Therapeutic application of fecal microbiota transplantation for neurological diseases: Exploring novel mechanisms and perspectives.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>January 01, 2026 - Alzheimer Research Update</title>
      <itunes:title>January 01, 2026 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">799ef3fa-c740-4aeb-b9d2-a58b41838189</guid>
      <link>https://share.transistor.fm/s/292446f6</link>
      <description>
        <![CDATA[January 01, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: RNA G-quadruplexes Mediated Protein Aggregation in Neurodegenerative Diseases.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[January 01, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: RNA G-quadruplexes Mediated Protein Aggregation in Neurodegenerative Diseases.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 01 Jan 2026 15:10:50 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/292446f6/5a6f653e.mp3" length="2242944" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>141</itunes:duration>
      <itunes:summary>
        <![CDATA[January 01, 2026 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: RNA G-quadruplexes Mediated Protein Aggregation in Neurodegenerative Diseases.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>December 31, 2025 - Alzheimer Research Update</title>
      <itunes:title>December 31, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">57aa31c1-1952-41bc-868f-e6ec999d1b9c</guid>
      <link>https://share.transistor.fm/s/76f44ee2</link>
      <description>
        <![CDATA[December 31, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Right Person, the Right Treatment, at the Right Time in Alzheimer's Disease: Insights From the 2025 Brain Aging Symposium.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[December 31, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Right Person, the Right Treatment, at the Right Time in Alzheimer's Disease: Insights From the 2025 Brain Aging Symposium.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 31 Dec 2025 15:05:10 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/76f44ee2/3b44c043.mp3" length="2317824" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>145</itunes:duration>
      <itunes:summary>
        <![CDATA[December 31, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Right Person, the Right Treatment, at the Right Time in Alzheimer's Disease: Insights From the 2025 Brain Aging Symposium.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>December 30, 2025 - Alzheimer Research Update</title>
      <itunes:title>December 30, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">86e4eb8a-2da5-4245-b99a-98f2943f59f7</guid>
      <link>https://share.transistor.fm/s/168ca1d1</link>
      <description>
        <![CDATA[December 30, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Right Person, the Right Treatment, at the Right Time in Alzheimer's Disease: Insights From the 2025 Brain Aging Symposium.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[December 30, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Right Person, the Right Treatment, at the Right Time in Alzheimer's Disease: Insights From the 2025 Brain Aging Symposium.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 30 Dec 2025 15:05:46 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/168ca1d1/5f4c227a.mp3" length="2851200" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>179</itunes:duration>
      <itunes:summary>
        <![CDATA[December 30, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Right Person, the Right Treatment, at the Right Time in Alzheimer's Disease: Insights From the 2025 Brain Aging Symposium.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>December 29, 2025 - Alzheimer Research Update</title>
      <itunes:title>December 29, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">97de33a7-1547-4476-b452-2290d8d4a6b1</guid>
      <link>https://share.transistor.fm/s/51dcebf2</link>
      <description>
        <![CDATA[December 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The 3xTg-AD Mouse Model of Alzheimer's Disease Exhibits Lifelong Reductions in Circulating Choline Despite Adequate Dietary Intake, With Sex-Specific Neuropathological and Behavioral Phenotypes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[December 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The 3xTg-AD Mouse Model of Alzheimer's Disease Exhibits Lifelong Reductions in Circulating Choline Despite Adequate Dietary Intake, With Sex-Specific Neuropathological and Behavioral Phenotypes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 29 Dec 2025 15:06:33 -0800</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/51dcebf2/e53e37ca.mp3" length="2461248" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>154</itunes:duration>
      <itunes:summary>
        <![CDATA[December 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The 3xTg-AD Mouse Model of Alzheimer's Disease Exhibits Lifelong Reductions in Circulating Choline Despite Adequate Dietary Intake, With Sex-Specific Neuropathological and Behavioral Phenotypes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 23, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 23, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">64e5e53a-8cd0-470a-b342-b1f7519d3084</guid>
      <link>https://share.transistor.fm/s/d64eb10f</link>
      <description>
        <![CDATA[October 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: LRRK2 kinase-mediated accumulation of lysosome-associated phospho-Rabs in tauopathies and synucleinopathies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: LRRK2 kinase-mediated accumulation of lysosome-associated phospho-Rabs in tauopathies and synucleinopathies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 23 Oct 2025 16:13:56 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/d64eb10f/879a8c2f.mp3" length="3756672" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>235</itunes:duration>
      <itunes:summary>
        <![CDATA[October 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: LRRK2 kinase-mediated accumulation of lysosome-associated phospho-Rabs in tauopathies and synucleinopathies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 22, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 22, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">84f345c4-8d7e-4fa4-a4d7-c39f89d55f8f</guid>
      <link>https://share.transistor.fm/s/f8942056</link>
      <description>
        <![CDATA[October 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Disease-associated microglia in neurodegenerative diseases: Friend or foe?

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Disease-associated microglia in neurodegenerative diseases: Friend or foe?

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 22 Oct 2025 16:10:39 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/f8942056/001550d9.mp3" length="1962432" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>123</itunes:duration>
      <itunes:summary>
        <![CDATA[October 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Disease-associated microglia in neurodegenerative diseases: Friend or foe?

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 21, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 21, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">34efdeb7-a9ae-471e-9e1b-30b84e6eb1ee</guid>
      <link>https://share.transistor.fm/s/671c492c</link>
      <description>
        <![CDATA[October 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer's Disease: A Bioinspired Alectinib Delivery Strategy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer's Disease: A Bioinspired Alectinib Delivery Strategy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 21 Oct 2025 16:11:38 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/671c492c/5aa30810.mp3" length="2514240" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>158</itunes:duration>
      <itunes:summary>
        <![CDATA[October 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer's Disease: A Bioinspired Alectinib Delivery Strategy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 20, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 20, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">a6271cfd-56af-4438-b998-f1be483d4bdd</guid>
      <link>https://share.transistor.fm/s/3d6ab4e8</link>
      <description>
        <![CDATA[October 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer's Disease: A Bioinspired Alectinib Delivery Strategy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer's Disease: A Bioinspired Alectinib Delivery Strategy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 20 Oct 2025 16:16:09 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/3d6ab4e8/86c57cbe.mp3" length="2104128" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>132</itunes:duration>
      <itunes:summary>
        <![CDATA[October 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for Synaptic Protection in Alzheimer's Disease: A Bioinspired Alectinib Delivery Strategy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 19, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 19, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b73d920a-66d4-410f-93bd-ecf29bd7dc09</guid>
      <link>https://share.transistor.fm/s/08a94921</link>
      <description>
        <![CDATA[October 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: CRISPR/Cas Genome Editing for Neurodegenerative Diseases: Mechanisms, Therapeutic Advances, and Clinical Prospects.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: CRISPR/Cas Genome Editing for Neurodegenerative Diseases: Mechanisms, Therapeutic Advances, and Clinical Prospects.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 19 Oct 2025 16:12:02 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/08a94921/964807cb.mp3" length="115200" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[October 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: CRISPR/Cas Genome Editing for Neurodegenerative Diseases: Mechanisms, Therapeutic Advances, and Clinical Prospects.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 18, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 18, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">38b6476d-b48c-487e-948f-91e9ab8564cf</guid>
      <link>https://share.transistor.fm/s/0e74400f</link>
      <description>
        <![CDATA[October 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Acrolein-Induced Alterations in Morphology and Stress Resilience in hiPSC-Derived Cortical Neurons.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Acrolein-Induced Alterations in Morphology and Stress Resilience in hiPSC-Derived Cortical Neurons.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 18 Oct 2025 16:13:35 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/0e74400f/f9fd13ec.mp3" length="113472" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[October 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Acrolein-Induced Alterations in Morphology and Stress Resilience in hiPSC-Derived Cortical Neurons.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 17, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 17, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d42e51a7-ab18-4523-97a6-4a3de9e8a1b9</guid>
      <link>https://share.transistor.fm/s/477afcb4</link>
      <description>
        <![CDATA[October 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 17 Oct 2025 16:13:02 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/477afcb4/4c10bf83.mp3" length="2847744" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>178</itunes:duration>
      <itunes:summary>
        <![CDATA[October 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Longitudinal Associations of Multimodal Core 1 Alzheimer Disease Biomarkers With Cognition in Aging and Preclinical Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 16, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 16, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0f0c01dd-3c99-47ed-baa3-4c0234af5918</guid>
      <link>https://share.transistor.fm/s/991e2ebd</link>
      <description>
        <![CDATA[October 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: First unified time-course of Alzheimer's-like pathology in the intracerebroventricular streptozotocin-rat model: A Systematic Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: First unified time-course of Alzheimer's-like pathology in the intracerebroventricular streptozotocin-rat model: A Systematic Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 16 Oct 2025 16:12:03 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/991e2ebd/465a744c.mp3" length="2764224" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>173</itunes:duration>
      <itunes:summary>
        <![CDATA[October 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: First unified time-course of Alzheimer's-like pathology in the intracerebroventricular streptozotocin-rat model: A Systematic Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 15, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 15, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6828ba8e-9e59-4ba5-8b15-5f46276481d6</guid>
      <link>https://share.transistor.fm/s/77d433f9</link>
      <description>
        <![CDATA[October 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Chaperone-mediated autophagy regulates neuronal activity by sex-specific remodelling of the synaptic proteome.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Chaperone-mediated autophagy regulates neuronal activity by sex-specific remodelling of the synaptic proteome.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 15 Oct 2025 16:11:47 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/77d433f9/1e2ba185.mp3" length="1920384" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>121</itunes:duration>
      <itunes:summary>
        <![CDATA[October 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Chaperone-mediated autophagy regulates neuronal activity by sex-specific remodelling of the synaptic proteome.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 14, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 14, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">52222ea1-a4f4-4e5c-974a-23e8dd4b615f</guid>
      <link>https://share.transistor.fm/s/1b5633bb</link>
      <description>
        <![CDATA[October 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Genetic and proteomic analysis identifies BAG3 as an amyloid-responsive regulator of neuronal proteostasis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Genetic and proteomic analysis identifies BAG3 as an amyloid-responsive regulator of neuronal proteostasis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 14 Oct 2025 16:11:27 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/1b5633bb/f3f85f31.mp3" length="2632896" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>165</itunes:duration>
      <itunes:summary>
        <![CDATA[October 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Genetic and proteomic analysis identifies BAG3 as an amyloid-responsive regulator of neuronal proteostasis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 13, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 13, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">690684e6-5548-4c4e-9f73-b2385ab9eb64</guid>
      <link>https://share.transistor.fm/s/1134ea3d</link>
      <description>
        <![CDATA[October 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Phosphodiesterase-5 Inhibition and Alzheimer's Disease Risk: A Mendelian Randomisation Study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Phosphodiesterase-5 Inhibition and Alzheimer's Disease Risk: A Mendelian Randomisation Study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 13 Oct 2025 16:13:24 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/1134ea3d/77c35ae4.mp3" length="2041344" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>128</itunes:duration>
      <itunes:summary>
        <![CDATA[October 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Phosphodiesterase-5 Inhibition and Alzheimer's Disease Risk: A Mendelian Randomisation Study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 12, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 12, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">f2af9be5-3439-4ac1-bd73-447dee0a96fc</guid>
      <link>https://share.transistor.fm/s/75be7355</link>
      <description>
        <![CDATA[October 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Photothermal nano-agents: an innovative trident weapon for accurate and effective treatment of alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Photothermal nano-agents: an innovative trident weapon for accurate and effective treatment of alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 12 Oct 2025 16:14:58 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/75be7355/209264fa.mp3" length="2634624" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>165</itunes:duration>
      <itunes:summary>
        <![CDATA[October 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Photothermal nano-agents: an innovative trident weapon for accurate and effective treatment of alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 11, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 11, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6dbec5c1-ba68-474d-b67b-462cb1453b66</guid>
      <link>https://share.transistor.fm/s/4b8ce658</link>
      <description>
        <![CDATA[October 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Crosstalk between anti-angiogenic and pro-angiogenic pathways in disease: Mechanisms and therapeutic strategies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Crosstalk between anti-angiogenic and pro-angiogenic pathways in disease: Mechanisms and therapeutic strategies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 11 Oct 2025 16:10:45 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/4b8ce658/bd1b4c80.mp3" length="114624" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[October 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Crosstalk between anti-angiogenic and pro-angiogenic pathways in disease: Mechanisms and therapeutic strategies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 10, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 10, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e7a127c5-5bb7-4327-8c84-739bbb0a8bcb</guid>
      <link>https://share.transistor.fm/s/d986bc3c</link>
      <description>
        <![CDATA[October 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Robust detection of femtogram-level Alzheimer's biomarkers using machine learning-enhanced graphene biosensors.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Robust detection of femtogram-level Alzheimer's biomarkers using machine learning-enhanced graphene biosensors.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 10 Oct 2025 16:22:28 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/d986bc3c/ed2bbbc3.mp3" length="114624" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[October 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Robust detection of femtogram-level Alzheimer's biomarkers using machine learning-enhanced graphene biosensors.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 09, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 09, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">61288b23-c74b-4d42-87cb-64954cce8fcf</guid>
      <link>https://share.transistor.fm/s/3f41bdfb</link>
      <description>
        <![CDATA[October 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Extracellular vesicle-based biosensors for Alzheimer's disease: A new frontier in precision diagnostics.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Extracellular vesicle-based biosensors for Alzheimer's disease: A new frontier in precision diagnostics.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 09 Oct 2025 16:22:06 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/3f41bdfb/28deffbc.mp3" length="2481984" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>156</itunes:duration>
      <itunes:summary>
        <![CDATA[October 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Extracellular vesicle-based biosensors for Alzheimer's disease: A new frontier in precision diagnostics.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 08, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 08, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2e45e0c5-7b99-4648-8793-6c4871ab534e</guid>
      <link>https://share.transistor.fm/s/7f55a0a3</link>
      <description>
        <![CDATA[October 08, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Identifying Distinct Spatiotemporal Patterns of Juxtacortical Microstructure in Alzheimer Disease Using Diffusion MRI-derived Free Water Fraction.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 08, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Identifying Distinct Spatiotemporal Patterns of Juxtacortical Microstructure in Alzheimer Disease Using Diffusion MRI-derived Free Water Fraction.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 08 Oct 2025 16:20:54 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/7f55a0a3/4f0a291a.mp3" length="2538432" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>159</itunes:duration>
      <itunes:summary>
        <![CDATA[October 08, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Identifying Distinct Spatiotemporal Patterns of Juxtacortical Microstructure in Alzheimer Disease Using Diffusion MRI-derived Free Water Fraction.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 07, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 07, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">885e38a3-cebf-4122-956d-0faa217e2ac0</guid>
      <link>https://share.transistor.fm/s/6128293c</link>
      <description>
        <![CDATA[October 07, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Identifying Distinct Spatiotemporal Patterns of Juxtacortical Microstructure in Alzheimer Disease Using Diffusion MRI-derived Free Water Fraction.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 07, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Identifying Distinct Spatiotemporal Patterns of Juxtacortical Microstructure in Alzheimer Disease Using Diffusion MRI-derived Free Water Fraction.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 07 Oct 2025 16:20:36 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/6128293c/8bb63e3b.mp3" length="114624" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[October 07, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Identifying Distinct Spatiotemporal Patterns of Juxtacortical Microstructure in Alzheimer Disease Using Diffusion MRI-derived Free Water Fraction.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 06, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 06, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">696be9e7-a402-4098-ba5b-5163054c906f</guid>
      <link>https://share.transistor.fm/s/01b2a6c8</link>
      <description>
        <![CDATA[October 06, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Canagliflozin Reprograms the Aging Hippocampus in Genetically Diverse UM-HET3 Mice and Attenuates Alzheimer's-Like Pathology.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 06, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Canagliflozin Reprograms the Aging Hippocampus in Genetically Diverse UM-HET3 Mice and Attenuates Alzheimer's-Like Pathology.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 06 Oct 2025 16:21:10 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/01b2a6c8/9b2734ea.mp3" length="2093184" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>131</itunes:duration>
      <itunes:summary>
        <![CDATA[October 06, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Canagliflozin Reprograms the Aging Hippocampus in Genetically Diverse UM-HET3 Mice and Attenuates Alzheimer's-Like Pathology.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 05, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 05, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6ff4374d-117e-470c-b877-854b6b1bf621</guid>
      <link>https://share.transistor.fm/s/507eb592</link>
      <description>
        <![CDATA[October 05, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: TDP-43 in Alzheimer's disease: pathophysiology and therapeutic strategies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 05, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: TDP-43 in Alzheimer's disease: pathophysiology and therapeutic strategies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 05 Oct 2025 16:22:10 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/507eb592/a9d765d4.mp3" length="2119680" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>133</itunes:duration>
      <itunes:summary>
        <![CDATA[October 05, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: TDP-43 in Alzheimer's disease: pathophysiology and therapeutic strategies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 04, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 04, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c671e030-58f7-4742-969d-a55015cf6225</guid>
      <link>https://share.transistor.fm/s/5eb19582</link>
      <description>
        <![CDATA[October 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Decoding Alzheimer's disease at the cellular level reveals promising combination therapy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Decoding Alzheimer's disease at the cellular level reveals promising combination therapy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 04 Oct 2025 16:21:48 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/5eb19582/2ed8a6ac.mp3" length="2414592" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>151</itunes:duration>
      <itunes:summary>
        <![CDATA[October 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Decoding Alzheimer's disease at the cellular level reveals promising combination therapy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 03, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 03, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0d2f6c55-93b8-4dce-8073-238ced89ca52</guid>
      <link>https://share.transistor.fm/s/73b152a4</link>
      <description>
        <![CDATA[October 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Longitudinal Association of a Polygenic Risk Score for Plasma T-Tau With Incident Alzheimer Dementia and Mild Cognitive Impairment.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Longitudinal Association of a Polygenic Risk Score for Plasma T-Tau With Incident Alzheimer Dementia and Mild Cognitive Impairment.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 03 Oct 2025 16:11:50 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/73b152a4/fa98d3bf.mp3" length="2567808" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>161</itunes:duration>
      <itunes:summary>
        <![CDATA[October 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Longitudinal Association of a Polygenic Risk Score for Plasma T-Tau With Incident Alzheimer Dementia and Mild Cognitive Impairment.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 02, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 02, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">31313b17-e222-4fd4-8dda-f41fa4e5954e</guid>
      <link>https://share.transistor.fm/s/a3d5a54b</link>
      <description>
        <![CDATA[October 02, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Visual interpretation of [(18)F]Florzolotau Tau-PET imaging for differentiating alzheimer's disease and progressive supranuclear palsy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 02, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Visual interpretation of [(18)F]Florzolotau Tau-PET imaging for differentiating alzheimer's disease and progressive supranuclear palsy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 02 Oct 2025 16:12:06 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/a3d5a54b/1c0640c1.mp3" length="2617920" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>164</itunes:duration>
      <itunes:summary>
        <![CDATA[October 02, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Visual interpretation of [(18)F]Florzolotau Tau-PET imaging for differentiating alzheimer's disease and progressive supranuclear palsy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>October 01, 2025 - Alzheimer Research Update</title>
      <itunes:title>October 01, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">1bd9dcaa-a6e6-4c47-b055-fd8ee419592c</guid>
      <link>https://share.transistor.fm/s/b3b14844</link>
      <description>
        <![CDATA[October 01, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Ceramide Links Alzheimer's Disease to Decreased Cancer Risk: A Lipid Behind the Enigma of Inverse Comorbidity.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[October 01, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Ceramide Links Alzheimer's Disease to Decreased Cancer Risk: A Lipid Behind the Enigma of Inverse Comorbidity.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 01 Oct 2025 16:13:15 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/b3b14844/bb6648f6.mp3" length="2448000" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>153</itunes:duration>
      <itunes:summary>
        <![CDATA[October 01, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Ceramide Links Alzheimer's Disease to Decreased Cancer Risk: A Lipid Behind the Enigma of Inverse Comorbidity.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 30, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 30, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">4b473489-34eb-4c25-86a7-414492a5af09</guid>
      <link>https://share.transistor.fm/s/bdd7e130</link>
      <description>
        <![CDATA[September 30, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Biliverdin reductase A is a major determinant of protective NRF2 signaling.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 30, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Biliverdin reductase A is a major determinant of protective NRF2 signaling.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 30 Sep 2025 16:11:07 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/bdd7e130/4340c3ee.mp3" length="2190528" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>137</itunes:duration>
      <itunes:summary>
        <![CDATA[September 30, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Biliverdin reductase A is a major determinant of protective NRF2 signaling.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 29, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 29, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e6307938-4c92-4023-9b8b-a1c645fcbec8</guid>
      <link>https://share.transistor.fm/s/dfcb87e0</link>
      <description>
        <![CDATA[September 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 29 Sep 2025 16:13:44 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/dfcb87e0/f016ffc3.mp3" length="2616768" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>164</itunes:duration>
      <itunes:summary>
        <![CDATA[September 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Exploring Autophagy Inducing Molecules: Targeting Diverse Pathways in Alzheimer's Disease Management.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 28, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 28, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2de0f9f2-0808-4977-a835-a7a93aa85a66</guid>
      <link>https://share.transistor.fm/s/fb501b7a</link>
      <description>
        <![CDATA[September 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Age-Associated Transcriptomic and Epigenetic Alterations in Mouse Hippocampus.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Age-Associated Transcriptomic and Epigenetic Alterations in Mouse Hippocampus.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 28 Sep 2025 16:20:43 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/fb501b7a/3a427a82.mp3" length="2166336" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>136</itunes:duration>
      <itunes:summary>
        <![CDATA[September 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Age-Associated Transcriptomic and Epigenetic Alterations in Mouse Hippocampus.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 27, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 27, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">21e21a43-8bc6-4673-bb9b-127c465de666</guid>
      <link>https://share.transistor.fm/s/7e2388c2</link>
      <description>
        <![CDATA[September 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 27 Sep 2025 16:11:07 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/7e2388c2/47a25b5e.mp3" length="2337984" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>147</itunes:duration>
      <itunes:summary>
        <![CDATA[September 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 26, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 26, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e2356bf3-0a8c-4142-86e9-610a6e30a772</guid>
      <link>https://share.transistor.fm/s/9e740c36</link>
      <description>
        <![CDATA[September 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 26 Sep 2025 16:09:37 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/9e740c36/8951717c.mp3" length="2161152" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>136</itunes:duration>
      <itunes:summary>
        <![CDATA[September 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Pathological Nexus and Multipronged Approaches to Mitigate Ferroptosis and Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 25, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 25, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0e91aae0-2782-40b5-839b-f43e1d4c182c</guid>
      <link>https://share.transistor.fm/s/9dbae220</link>
      <description>
        <![CDATA[September 25, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: New frontier for epilepsy treatment through targeting cellular senescence.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 25, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: New frontier for epilepsy treatment through targeting cellular senescence.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 25 Sep 2025 16:11:49 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/9dbae220/43150740.mp3" length="114624" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[September 25, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: New frontier for epilepsy treatment through targeting cellular senescence.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 24, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 24, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">964a4d94-6f36-4039-9a6c-ce7334e8e0c3</guid>
      <link>https://share.transistor.fm/s/ada8633a</link>
      <description>
        <![CDATA[September 24, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Exploring transfer learning techniques for classifying Alzheimer's disease with rs-fMRI.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 24, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Exploring transfer learning techniques for classifying Alzheimer's disease with rs-fMRI.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 24 Sep 2025 16:16:00 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/ada8633a/dc91faf6.mp3" length="1759680" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>110</itunes:duration>
      <itunes:summary>
        <![CDATA[September 24, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Exploring transfer learning techniques for classifying Alzheimer's disease with rs-fMRI.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 23, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 23, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">1367eee7-1b38-4a32-a22a-6517ba068483</guid>
      <link>https://share.transistor.fm/s/2933786a</link>
      <description>
        <![CDATA[September 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cross-Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cross-Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 23 Sep 2025 16:15:08 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/2933786a/8184f8fe.mp3" length="1801152" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>113</itunes:duration>
      <itunes:summary>
        <![CDATA[September 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cross-Sectional FDG in Down Syndrome and Autosomal Dominant Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 22, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 22, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7eed6610-07c4-4f2c-850b-b3432642fec3</guid>
      <link>https://share.transistor.fm/s/81faf54a</link>
      <description>
        <![CDATA[September 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Omega-3 polyunsaturated fatty acids in neurodegenerative disorders: Mixed designs = mixed results.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Omega-3 polyunsaturated fatty acids in neurodegenerative disorders: Mixed designs = mixed results.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 22 Sep 2025 16:14:38 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/81faf54a/d65a3ce8.mp3" length="1915776" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>120</itunes:duration>
      <itunes:summary>
        <![CDATA[September 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Omega-3 polyunsaturated fatty acids in neurodegenerative disorders: Mixed designs = mixed results.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 21, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 21, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">bfe9bee9-3d17-4dfc-9d27-11874526549d</guid>
      <link>https://share.transistor.fm/s/a454ed05</link>
      <description>
        <![CDATA[September 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Are amyloid-based materials conducive to tissue engineering?

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Are amyloid-based materials conducive to tissue engineering?

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 21 Sep 2025 16:11:56 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/a454ed05/6c1a115b.mp3" length="1832832" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>115</itunes:duration>
      <itunes:summary>
        <![CDATA[September 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Are amyloid-based materials conducive to tissue engineering?

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 20, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 20, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">76e0d285-a18b-4806-a1c4-23a8ff835356</guid>
      <link>https://share.transistor.fm/s/bd30ac21</link>
      <description>
        <![CDATA[September 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors: A Nationwide, Register-Based Cohort Study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors: A Nationwide, Register-Based Cohort Study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 20 Sep 2025 16:14:35 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/bd30ac21/11da3bae.mp3" length="2463552" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>154</itunes:duration>
      <itunes:summary>
        <![CDATA[September 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors: A Nationwide, Register-Based Cohort Study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 19, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 19, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">3e704d27-03e0-4871-b665-4ea8c026f5da</guid>
      <link>https://share.transistor.fm/s/db4d61fc</link>
      <description>
        <![CDATA[September 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Mechanism of oxidative stress and neurotoxicity associated with heme and copper-Aβ relevant to Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Mechanism of oxidative stress and neurotoxicity associated with heme and copper-Aβ relevant to Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 19 Sep 2025 16:17:00 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/db4d61fc/f2b3776a.mp3" length="1893312" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>119</itunes:duration>
      <itunes:summary>
        <![CDATA[September 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Mechanism of oxidative stress and neurotoxicity associated with heme and copper-Aβ relevant to Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 18, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 18, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">1395ea79-7fe1-4390-b2a0-4c1830195088</guid>
      <link>https://share.transistor.fm/s/e6cc2fc9</link>
      <description>
        <![CDATA[September 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Mechanism of oxidative stress and neurotoxicity associated with heme and copper-Aβ relevant to Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Mechanism of oxidative stress and neurotoxicity associated with heme and copper-Aβ relevant to Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 18 Sep 2025 16:14:06 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/e6cc2fc9/d3826538.mp3" length="2136384" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>134</itunes:duration>
      <itunes:summary>
        <![CDATA[September 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Mechanism of oxidative stress and neurotoxicity associated with heme and copper-Aβ relevant to Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 17, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 17, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">830f3cf3-dca2-4179-8a11-9f2a6e47f5f1</guid>
      <link>https://share.transistor.fm/s/7b25a088</link>
      <description>
        <![CDATA[September 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Microstructural Bias in the Assessment of Periventricular Flow as Revealed in Postmortem Brains.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Microstructural Bias in the Assessment of Periventricular Flow as Revealed in Postmortem Brains.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 17 Sep 2025 16:13:03 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/7b25a088/e1eeab3d.mp3" length="2098944" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>132</itunes:duration>
      <itunes:summary>
        <![CDATA[September 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Microstructural Bias in the Assessment of Periventricular Flow as Revealed in Postmortem Brains.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 16, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 16, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7914610c-4671-49ca-8017-2dcf03347cdb</guid>
      <link>https://share.transistor.fm/s/2c282b53</link>
      <description>
        <![CDATA[September 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Microstructural Bias in the Assessment of Periventricular Flow as Revealed in Postmortem Brains.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Microstructural Bias in the Assessment of Periventricular Flow as Revealed in Postmortem Brains.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 16 Sep 2025 16:15:59 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/2c282b53/d7fa03da.mp3" length="2157120" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>135</itunes:duration>
      <itunes:summary>
        <![CDATA[September 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Microstructural Bias in the Assessment of Periventricular Flow as Revealed in Postmortem Brains.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 15, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 15, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">bbd50f11-be3e-41a7-a65c-c0bd3750e8d7</guid>
      <link>https://share.transistor.fm/s/d8ef64bc</link>
      <description>
        <![CDATA[September 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Differences and overlaps in TDP-43 pathology of 'pure' LATE-NC compared to LATE-NC coexisting with Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Differences and overlaps in TDP-43 pathology of 'pure' LATE-NC compared to LATE-NC coexisting with Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 15 Sep 2025 16:14:10 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/d8ef64bc/6a50a6e8.mp3" length="2544192" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>160</itunes:duration>
      <itunes:summary>
        <![CDATA[September 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Differences and overlaps in TDP-43 pathology of 'pure' LATE-NC compared to LATE-NC coexisting with Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 14, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 14, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6a36cc2c-d1ee-48ae-8af4-17a91eccbe38</guid>
      <link>https://share.transistor.fm/s/3cf513ae</link>
      <description>
        <![CDATA[September 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: IterMask3D: Unsupervised anomaly detection and segmentation with test-time iterative mask refinement in 3D brain MRI.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: IterMask3D: Unsupervised anomaly detection and segmentation with test-time iterative mask refinement in 3D brain MRI.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 14 Sep 2025 16:18:37 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/3cf513ae/fcdbd58b.mp3" length="2563200" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>161</itunes:duration>
      <itunes:summary>
        <![CDATA[September 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: IterMask3D: Unsupervised anomaly detection and segmentation with test-time iterative mask refinement in 3D brain MRI.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 13, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 13, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ab28ab96-6af5-46af-a699-20926f4ea7ad</guid>
      <link>https://share.transistor.fm/s/765dc50a</link>
      <description>
        <![CDATA[September 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Visual Classification of Tau-PET Detects 4 Subtypes With Different Long-Term Outcomes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Visual Classification of Tau-PET Detects 4 Subtypes With Different Long-Term Outcomes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 13 Sep 2025 16:02:51 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/765dc50a/0e9d85d2.mp3" length="2392704" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>150</itunes:duration>
      <itunes:summary>
        <![CDATA[September 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Visual Classification of Tau-PET Detects 4 Subtypes With Different Long-Term Outcomes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 12, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 12, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ee42b948-2946-4d18-9da8-b6f6ad90e2f0</guid>
      <link>https://share.transistor.fm/s/9963c75d</link>
      <description>
        <![CDATA[September 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Visual Classification of Tau-PET Detects 4 Subtypes With Different Long-Term Outcomes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Visual Classification of Tau-PET Detects 4 Subtypes With Different Long-Term Outcomes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 12 Sep 2025 16:02:53 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/9963c75d/60a01f70.mp3" length="2287872" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>143</itunes:duration>
      <itunes:summary>
        <![CDATA[September 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Visual Classification of Tau-PET Detects 4 Subtypes With Different Long-Term Outcomes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 11, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 11, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">561b523b-18ae-4fbe-88f2-8edc179ae8e2</guid>
      <link>https://share.transistor.fm/s/a1569228</link>
      <description>
        <![CDATA[September 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: ABCA7 variants impact phosphatidylcholine and mitochondria in neurons.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: ABCA7 variants impact phosphatidylcholine and mitochondria in neurons.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 11 Sep 2025 16:00:43 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/a1569228/5bb98c4c.mp3" length="271296" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>17</itunes:duration>
      <itunes:summary>
        <![CDATA[September 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: ABCA7 variants impact phosphatidylcholine and mitochondria in neurons.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 10, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 10, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">de2ca6d7-b49c-44a3-a5e0-69a483de1521</guid>
      <link>https://share.transistor.fm/s/50a14c71</link>
      <description>
        <![CDATA[September 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cholinergic G protein-coupled bile acid receptor 1 (TGR5/GPBA) in the medial septal orchestrates adult hippocampal neurogenesis and cognition in Alzheimer's disease mice.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cholinergic G protein-coupled bile acid receptor 1 (TGR5/GPBA) in the medial septal orchestrates adult hippocampal neurogenesis and cognition in Alzheimer's disease mice.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 10 Sep 2025 16:00:33 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/50a14c71/7236f19f.mp3" length="262656" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>17</itunes:duration>
      <itunes:summary>
        <![CDATA[September 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cholinergic G protein-coupled bile acid receptor 1 (TGR5/GPBA) in the medial septal orchestrates adult hippocampal neurogenesis and cognition in Alzheimer's disease mice.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 09, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 09, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">005e17ce-8c7a-4c5f-8413-fe0d65dfd460</guid>
      <link>https://share.transistor.fm/s/b01f400b</link>
      <description>
        <![CDATA[September 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Hybridoma-inspired strategy crafts tailored multifunctional exosomes for precision therapy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Hybridoma-inspired strategy crafts tailored multifunctional exosomes for precision therapy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 09 Sep 2025 16:00:41 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/b01f400b/9cd4c642.mp3" length="262656" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>17</itunes:duration>
      <itunes:summary>
        <![CDATA[September 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Hybridoma-inspired strategy crafts tailored multifunctional exosomes for precision therapy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 08, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 08, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">fa04e59b-a7a5-42a8-8b24-e51f4d278516</guid>
      <link>https://share.transistor.fm/s/1aed0d6a</link>
      <description>
        <![CDATA[September 08, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cerebrovascular protective functions of amyloid precursor protein: Progress and therapeutic prospects.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 08, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cerebrovascular protective functions of amyloid precursor protein: Progress and therapeutic prospects.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 08 Sep 2025 16:02:14 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/1aed0d6a/8be33e22.mp3" length="114624" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[September 08, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cerebrovascular protective functions of amyloid precursor protein: Progress and therapeutic prospects.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 07, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 07, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">0d0f482c-c616-4a1a-92c7-8f7460920538</guid>
      <link>https://share.transistor.fm/s/ab9dbc7d</link>
      <description>
        <![CDATA[September 07, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Current and Emerging Pharmacological Approaches to Agitation in Alzheimer's Disease: A Narrative Review of New and Repurposed Therapies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 07, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Current and Emerging Pharmacological Approaches to Agitation in Alzheimer's Disease: A Narrative Review of New and Repurposed Therapies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 07 Sep 2025 16:02:59 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/ab9dbc7d/ad568355.mp3" length="1904832" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>120</itunes:duration>
      <itunes:summary>
        <![CDATA[September 07, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Current and Emerging Pharmacological Approaches to Agitation in Alzheimer's Disease: A Narrative Review of New and Repurposed Therapies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 05, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 05, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2a904999-18ed-40e1-8d4e-8457a0032f09</guid>
      <link>https://share.transistor.fm/s/b3a712df</link>
      <description>
        <![CDATA[September 05, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 05, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 05 Sep 2025 16:02:52 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/b3a712df/2b3503c3.mp3" length="1761408" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>111</itunes:duration>
      <itunes:summary>
        <![CDATA[September 05, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 04, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 04, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2ce9842e-b2e1-4e28-9419-58f948f6319f</guid>
      <link>https://share.transistor.fm/s/97cdd154</link>
      <description>
        <![CDATA[September 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: PICALM Alzheimer's risk allele causes aberrant lipid droplets in microglia.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: PICALM Alzheimer's risk allele causes aberrant lipid droplets in microglia.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 04 Sep 2025 16:02:15 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/97cdd154/7b9ef379.mp3" length="1744128" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>110</itunes:duration>
      <itunes:summary>
        <![CDATA[September 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: PICALM Alzheimer's risk allele causes aberrant lipid droplets in microglia.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 03, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 03, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">25921062-4cde-45c3-8919-5d5a6c1851f7</guid>
      <link>https://share.transistor.fm/s/f14b8e61</link>
      <description>
        <![CDATA[September 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Medication Use and Quality of Life in Older Adults with Personality Disorders.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Medication Use and Quality of Life in Older Adults with Personality Disorders.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 03 Sep 2025 16:00:32 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/f14b8e61/46d75ab4.mp3" length="262080" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>17</itunes:duration>
      <itunes:summary>
        <![CDATA[September 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Medication Use and Quality of Life in Older Adults with Personality Disorders.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 03, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 03, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">511d43bb-6587-4055-85d8-d965a50bead2</guid>
      <link>https://share.transistor.fm/s/592570d3</link>
      <description>
        <![CDATA[September 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Medication Use and Quality of Life in Older Adults with Personality Disorders.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Medication Use and Quality of Life in Older Adults with Personality Disorders.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 03 Sep 2025 16:00:16 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/592570d3/1051d034.mp3" length="262656" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>17</itunes:duration>
      <itunes:summary>
        <![CDATA[September 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Medication Use and Quality of Life in Older Adults with Personality Disorders.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>September 02, 2025 - Alzheimer Research Update</title>
      <itunes:title>September 02, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c72c9add-f26c-4823-93ae-2095038c78d7</guid>
      <link>https://share.transistor.fm/s/945a284d</link>
      <description>
        <![CDATA[September 02, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Metabolome informs about the chemical exposome and links to brain health.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[September 02, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Metabolome informs about the chemical exposome and links to brain health.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 02 Sep 2025 16:00:40 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/945a284d/d2dd009b.mp3" length="260352" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>17</itunes:duration>
      <itunes:summary>
        <![CDATA[September 02, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Metabolome informs about the chemical exposome and links to brain health.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 29, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 29, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">20919b72-fd7e-4022-9b5e-8a2e1f9a8832</guid>
      <link>https://share.transistor.fm/s/3a838be8</link>
      <description>
        <![CDATA[August 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Associations between trajectories of plasma biomarkers for Alzheimer's disease, brain structures, and cognitive function: a prospective cohort study in the UK Biobank.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Associations between trajectories of plasma biomarkers for Alzheimer's disease, brain structures, and cognitive function: a prospective cohort study in the UK Biobank.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 29 Aug 2025 16:02:05 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/3a838be8/69f3d8d2.mp3" length="114624" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[August 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Associations between trajectories of plasma biomarkers for Alzheimer's disease, brain structures, and cognitive function: a prospective cohort study in the UK Biobank.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 28, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 28, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">a72aa1f0-183d-4320-9b7a-cba80ccc41a6</guid>
      <link>https://share.transistor.fm/s/80baeb00</link>
      <description>
        <![CDATA[August 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Recent Advances and Future Directions in Alzheimer's Disease Genetic Research.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Recent Advances and Future Directions in Alzheimer's Disease Genetic Research.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 28 Aug 2025 16:02:21 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/80baeb00/d1e48665.mp3" length="1503936" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>94</itunes:duration>
      <itunes:summary>
        <![CDATA[August 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Recent Advances and Future Directions in Alzheimer's Disease Genetic Research.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 27, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 27, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">8a5a92a7-0318-4bf1-8bae-3b1e91bab16b</guid>
      <link>https://share.transistor.fm/s/679c7684</link>
      <description>
        <![CDATA[August 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: UnCOT-AD: Unpaired Cross-Omics Translation Enables Multi-Omics Integration for Alzheimer's Disease Prediction.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: UnCOT-AD: Unpaired Cross-Omics Translation Enables Multi-Omics Integration for Alzheimer's Disease Prediction.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 27 Aug 2025 16:02:38 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/679c7684/1ef56fd6.mp3" length="1903104" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>119</itunes:duration>
      <itunes:summary>
        <![CDATA[August 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: UnCOT-AD: Unpaired Cross-Omics Translation Enables Multi-Omics Integration for Alzheimer's Disease Prediction.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 26, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 26, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">4fdc1f23-6e0c-431e-bedd-bde76a44f0e1</guid>
      <link>https://share.transistor.fm/s/0fcbb119</link>
      <description>
        <![CDATA[August 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Interplay of genetic predisposition, plasma metabolome and Mediterranean diet in dementia risk and cognitive function.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Interplay of genetic predisposition, plasma metabolome and Mediterranean diet in dementia risk and cognitive function.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 26 Aug 2025 16:02:19 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/0fcbb119/240cb304.mp3" length="1531584" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>96</itunes:duration>
      <itunes:summary>
        <![CDATA[August 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Interplay of genetic predisposition, plasma metabolome and Mediterranean diet in dementia risk and cognitive function.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 25, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 25, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7c909da8-f1ab-445a-92a6-9d21c9aee2ee</guid>
      <link>https://share.transistor.fm/s/0fddde25</link>
      <description>
        <![CDATA[August 25, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 25, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 25 Aug 2025 16:02:17 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/0fddde25/4068e639.mp3" length="1747008" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>110</itunes:duration>
      <itunes:summary>
        <![CDATA[August 25, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Post-Translationally Modified Proteoforms as Biomarkers: From Discovery to Clinical Use.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 24, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 24, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">835bcd64-9419-4d28-afdb-dfec15955965</guid>
      <link>https://share.transistor.fm/s/f6733602</link>
      <description>
        <![CDATA[August 24, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: ECL-CRISPR array for multiplexed detection of miRNAs.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 24, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: ECL-CRISPR array for multiplexed detection of miRNAs.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 24 Aug 2025 16:02:16 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/f6733602/2afc37c9.mp3" length="113472" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[August 24, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: ECL-CRISPR array for multiplexed detection of miRNAs.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 23, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 23, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">36f6157c-cce0-4907-87c4-740d3e9c794e</guid>
      <link>https://share.transistor.fm/s/df42dcd0</link>
      <description>
        <![CDATA[August 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Quantum Dots in Neurotheranostics for the Treatment of Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Quantum Dots in Neurotheranostics for the Treatment of Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 23 Aug 2025 16:02:15 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/df42dcd0/45d0a32a.mp3" length="2183616" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>137</itunes:duration>
      <itunes:summary>
        <![CDATA[August 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Quantum Dots in Neurotheranostics for the Treatment of Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 22, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 22, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6e42b757-f482-4295-9371-e76977afec18</guid>
      <link>https://share.transistor.fm/s/392eeca0</link>
      <description>
        <![CDATA[August 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Leveraging functional annotations to map rare variants associated with Alzheimer disease with gruyere.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Leveraging functional annotations to map rare variants associated with Alzheimer disease with gruyere.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 22 Aug 2025 16:02:19 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/392eeca0/2a684910.mp3" length="1942848" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>122</itunes:duration>
      <itunes:summary>
        <![CDATA[August 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Leveraging functional annotations to map rare variants associated with Alzheimer disease with gruyere.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 21, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 21, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7cd3c14b-7af7-4407-9249-5084fafbd2f7</guid>
      <link>https://share.transistor.fm/s/e0d22c9e</link>
      <description>
        <![CDATA[August 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Functional, Cognitive, Physical, and Vascular Outcomes 9 Years After Lacunar and Mild Cortical Ischemic Stroke.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Functional, Cognitive, Physical, and Vascular Outcomes 9 Years After Lacunar and Mild Cortical Ischemic Stroke.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 21 Aug 2025 16:02:46 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/e0d22c9e/73c2e591.mp3" length="1926720" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>121</itunes:duration>
      <itunes:summary>
        <![CDATA[August 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Functional, Cognitive, Physical, and Vascular Outcomes 9 Years After Lacunar and Mild Cortical Ischemic Stroke.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 20, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 20, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6049bdcb-515b-4d35-9418-69b3b299c36d</guid>
      <link>https://share.transistor.fm/s/88b571f8</link>
      <description>
        <![CDATA[August 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Integrating MRI Volume and Plasma p-Tau217 for Amyloid Risk Stratification in Early-Stage Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Integrating MRI Volume and Plasma p-Tau217 for Amyloid Risk Stratification in Early-Stage Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 20 Aug 2025 16:02:18 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/88b571f8/5a8d0007.mp3" length="1863936" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>117</itunes:duration>
      <itunes:summary>
        <![CDATA[August 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Integrating MRI Volume and Plasma p-Tau217 for Amyloid Risk Stratification in Early-Stage Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 19, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 19, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">da31442b-2ee1-40ec-bfec-2651a13b7624</guid>
      <link>https://share.transistor.fm/s/2b777551</link>
      <description>
        <![CDATA[August 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Lipoprotein(a) and risk of dementia: findings from three cohort studies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Lipoprotein(a) and risk of dementia: findings from three cohort studies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 19 Aug 2025 16:02:30 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/2b777551/56c78275.mp3" length="2249280" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>141</itunes:duration>
      <itunes:summary>
        <![CDATA[August 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Lipoprotein(a) and risk of dementia: findings from three cohort studies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 18, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 18, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b1f828b9-719a-4315-993b-b5a07272d058</guid>
      <link>https://share.transistor.fm/s/e7b9b513</link>
      <description>
        <![CDATA[August 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Lipoprotein(a) and risk of dementia: findings from three cohort studies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Lipoprotein(a) and risk of dementia: findings from three cohort studies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 18 Aug 2025 16:02:20 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/e7b9b513/845f580b.mp3" length="2319552" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>145</itunes:duration>
      <itunes:summary>
        <![CDATA[August 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Lipoprotein(a) and risk of dementia: findings from three cohort studies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 17, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 17, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">cf8fa03a-d7e5-4d3e-b18f-b60b7cc7e1b2</guid>
      <link>https://share.transistor.fm/s/f5bf708f</link>
      <description>
        <![CDATA[August 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: SMAS: Structural MRI-based AD Score using Bayesian supervised VAE.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: SMAS: Structural MRI-based AD Score using Bayesian supervised VAE.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 17 Aug 2025 16:02:15 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/f5bf708f/af718354.mp3" length="2004480" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>126</itunes:duration>
      <itunes:summary>
        <![CDATA[August 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: SMAS: Structural MRI-based AD Score using Bayesian supervised VAE.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 16, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 16, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">49c3b6f8-c299-4bf2-9948-c10770ec9c86</guid>
      <link>https://share.transistor.fm/s/2c3e7708</link>
      <description>
        <![CDATA[August 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Understanding the influence of TLR-Mediated Immune System on Necroptosis-Induced Neurodegeneration in Parkinson's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Understanding the influence of TLR-Mediated Immune System on Necroptosis-Induced Neurodegeneration in Parkinson's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 16 Aug 2025 16:02:14 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/2c3e7708/a78041f2.mp3" length="1851264" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>116</itunes:duration>
      <itunes:summary>
        <![CDATA[August 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Understanding the influence of TLR-Mediated Immune System on Necroptosis-Induced Neurodegeneration in Parkinson's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 15, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 15, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6fda59f7-93cb-4c14-91d0-f5c9482020c5</guid>
      <link>https://share.transistor.fm/s/7d9c1ee1</link>
      <description>
        <![CDATA[August 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Insomnia Phenotypes, Cardiovascular Risk and Their Link to Brain Health.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Insomnia Phenotypes, Cardiovascular Risk and Their Link to Brain Health.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 15 Aug 2025 16:02:34 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/7d9c1ee1/e85f9c01.mp3" length="1811520" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>114</itunes:duration>
      <itunes:summary>
        <![CDATA[August 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Insomnia Phenotypes, Cardiovascular Risk and Their Link to Brain Health.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 14, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 14, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6d0fc76a-b30d-43dd-852b-fe3a48b71cc4</guid>
      <link>https://share.transistor.fm/s/52f74525</link>
      <description>
        <![CDATA[August 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cardiovascular damage, arrhythmogenesis and overlapping Alzheimer and Parkinson's diseases and TDP-43 pathology start in pediatric and young adult urban populations: Magnetic ultrafine particulate matter and industrial particles with motion behavior play a key role.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cardiovascular damage, arrhythmogenesis and overlapping Alzheimer and Parkinson's diseases and TDP-43 pathology start in pediatric and young adult urban populations: Magnetic ultrafine particulate matter and industrial particles with motion behavior play a key role.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 14 Aug 2025 16:02:31 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/52f74525/9bc1c40e.mp3" length="2002176" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>126</itunes:duration>
      <itunes:summary>
        <![CDATA[August 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cardiovascular damage, arrhythmogenesis and overlapping Alzheimer and Parkinson's diseases and TDP-43 pathology start in pediatric and young adult urban populations: Magnetic ultrafine particulate matter and industrial particles with motion behavior play a key role.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 13, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 13, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">63dc4473-05e7-469f-a43d-7bc084d8f230</guid>
      <link>https://share.transistor.fm/s/7125c159</link>
      <description>
        <![CDATA[August 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Addressing Digital Disparities in Alzheimer Disease by Improving Access to Alzheimer Resources for Spanish-Speaking Latino or Latina Individuals in Los Angeles County: Mixed Methods Study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Addressing Digital Disparities in Alzheimer Disease by Improving Access to Alzheimer Resources for Spanish-Speaking Latino or Latina Individuals in Los Angeles County: Mixed Methods Study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 13 Aug 2025 16:02:31 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/7125c159/42ce5180.mp3" length="3197952" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>200</itunes:duration>
      <itunes:summary>
        <![CDATA[August 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Addressing Digital Disparities in Alzheimer Disease by Improving Access to Alzheimer Resources for Spanish-Speaking Latino or Latina Individuals in Los Angeles County: Mixed Methods Study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 12, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 12, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">9daa9961-c41a-4130-873c-4d772018a598</guid>
      <link>https://share.transistor.fm/s/f7968a8e</link>
      <description>
        <![CDATA[August 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Potentiation of mitochondrial function by mitoDREADD-G(s) reverses pharmacological and neurodegenerative cognitive impairment in mice.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Potentiation of mitochondrial function by mitoDREADD-G(s) reverses pharmacological and neurodegenerative cognitive impairment in mice.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 12 Aug 2025 16:02:29 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/f7968a8e/87c79087.mp3" length="1497024" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>94</itunes:duration>
      <itunes:summary>
        <![CDATA[August 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Potentiation of mitochondrial function by mitoDREADD-G(s) reverses pharmacological and neurodegenerative cognitive impairment in mice.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 11, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 11, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e85a2a32-f5ce-463b-878d-7e28600b08d3</guid>
      <link>https://share.transistor.fm/s/e73e2145</link>
      <description>
        <![CDATA[August 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Brain transcriptomics highlight abundant gene expression and splicing alterations in non-neuronal cells in aFTLD-U.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Brain transcriptomics highlight abundant gene expression and splicing alterations in non-neuronal cells in aFTLD-U.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 11 Aug 2025 16:02:24 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/e73e2145/42de4493.mp3" length="1797696" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>113</itunes:duration>
      <itunes:summary>
        <![CDATA[August 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Brain transcriptomics highlight abundant gene expression and splicing alterations in non-neuronal cells in aFTLD-U.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 10, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 10, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">83fa1d96-e37d-40b2-a5e6-3772ebfbc019</guid>
      <link>https://share.transistor.fm/s/9ca61929</link>
      <description>
        <![CDATA[August 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Pathogens accelerate features of human aging: A review of molecular mechanisms.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Pathogens accelerate features of human aging: A review of molecular mechanisms.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 10 Aug 2025 16:02:15 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/9ca61929/a3abacb4.mp3" length="1816704" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>114</itunes:duration>
      <itunes:summary>
        <![CDATA[August 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Pathogens accelerate features of human aging: A review of molecular mechanisms.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 09, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 09, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">142ffea3-d044-4583-a72e-2983a196bc2d</guid>
      <link>https://share.transistor.fm/s/f16282c8</link>
      <description>
        <![CDATA[August 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Associations of Longitudinal Changes in Blood Biomarkers of Dementia With the Proportion of Genetically Inferred African Ancestry.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Associations of Longitudinal Changes in Blood Biomarkers of Dementia With the Proportion of Genetically Inferred African Ancestry.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 09 Aug 2025 16:02:27 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/f16282c8/a5e037fb.mp3" length="1994112" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>125</itunes:duration>
      <itunes:summary>
        <![CDATA[August 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Associations of Longitudinal Changes in Blood Biomarkers of Dementia With the Proportion of Genetically Inferred African Ancestry.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 08, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 08, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2d832e6f-1dc3-4a8e-a34b-ee72ecd337fc</guid>
      <link>https://share.transistor.fm/s/b265892e</link>
      <description>
        <![CDATA[August 08, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Associations of Longitudinal Changes in Blood Biomarkers of Dementia With the Proportion of Genetically Inferred African Ancestry.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 08, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Associations of Longitudinal Changes in Blood Biomarkers of Dementia With the Proportion of Genetically Inferred African Ancestry.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 08 Aug 2025 16:02:09 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/b265892e/4dda7082.mp3" length="1850688" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>116</itunes:duration>
      <itunes:summary>
        <![CDATA[August 08, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Associations of Longitudinal Changes in Blood Biomarkers of Dementia With the Proportion of Genetically Inferred African Ancestry.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 07, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 07, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d01f8ed1-5969-416e-a24d-b68611660f77</guid>
      <link>https://share.transistor.fm/s/47be76b9</link>
      <description>
        <![CDATA[August 07, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Alzheimer's Disease-Associated Amyloid Beta Precursor Protein Prevents Aging Stress-Induced Mitophagy and Fumarate Depletion to Improve Anti-Tumor Immunity.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 07, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Alzheimer's Disease-Associated Amyloid Beta Precursor Protein Prevents Aging Stress-Induced Mitophagy and Fumarate Depletion to Improve Anti-Tumor Immunity.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 07 Aug 2025 16:02:51 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/47be76b9/eac72b91.mp3" length="2325888" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>146</itunes:duration>
      <itunes:summary>
        <![CDATA[August 07, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Alzheimer's Disease-Associated Amyloid Beta Precursor Protein Prevents Aging Stress-Induced Mitophagy and Fumarate Depletion to Improve Anti-Tumor Immunity.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 06, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 06, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">5f89cb02-fca2-4f05-88a3-ed7dd2016281</guid>
      <link>https://share.transistor.fm/s/353cf725</link>
      <description>
        <![CDATA[August 06, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 06, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 06 Aug 2025 16:02:30 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/353cf725/7e26bc66.mp3" length="2119104" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>133</itunes:duration>
      <itunes:summary>
        <![CDATA[August 06, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 04, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 04, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ba77e24f-24bc-4b0e-bae1-8464e43db547</guid>
      <link>https://share.transistor.fm/s/7f70381c</link>
      <description>
        <![CDATA[August 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Promoting Spike-Timing-Dependent Plasticity via Paired Associative Stimulation: From Healthy Subjects to Clinical Applications.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Promoting Spike-Timing-Dependent Plasticity via Paired Associative Stimulation: From Healthy Subjects to Clinical Applications.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 04 Aug 2025 16:02:18 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/7f70381c/8a3e02c4.mp3" length="112320" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[August 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Promoting Spike-Timing-Dependent Plasticity via Paired Associative Stimulation: From Healthy Subjects to Clinical Applications.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 03, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 03, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b2c6fd5e-1765-4288-91c2-ce612fd55789</guid>
      <link>https://share.transistor.fm/s/dec8694c</link>
      <description>
        <![CDATA[August 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Single-cell multiregion epigenomic rewiring in Alzheimer's disease progression and cognitive resilience.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Single-cell multiregion epigenomic rewiring in Alzheimer's disease progression and cognitive resilience.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 03 Aug 2025 16:02:11 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/dec8694c/ca4ebe4e.mp3" length="1456128" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>92</itunes:duration>
      <itunes:summary>
        <![CDATA[August 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Single-cell multiregion epigenomic rewiring in Alzheimer's disease progression and cognitive resilience.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 02, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 02, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">24155df6-6f90-4eb1-ae26-c661184004a2</guid>
      <link>https://share.transistor.fm/s/5e1669e4</link>
      <description>
        <![CDATA[August 02, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Digital Therapeutics for Alzheimer's and Parkinson's Diseases: Current Trends and Future Perspectives.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 02, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Digital Therapeutics for Alzheimer's and Parkinson's Diseases: Current Trends and Future Perspectives.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 02 Aug 2025 16:02:12 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/5e1669e4/377faa5d.mp3" length="112320" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[August 02, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Digital Therapeutics for Alzheimer's and Parkinson's Diseases: Current Trends and Future Perspectives.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>August 01, 2025 - Alzheimer Research Update</title>
      <itunes:title>August 01, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">57141a8b-3525-448b-b463-26896d9aff94</guid>
      <link>https://share.transistor.fm/s/e8d7d56a</link>
      <description>
        <![CDATA[August 01, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Digital Therapeutics for Alzheimer's and Parkinson's Diseases: Current Trends and Future Perspectives.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[August 01, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Digital Therapeutics for Alzheimer's and Parkinson's Diseases: Current Trends and Future Perspectives.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 01 Aug 2025 16:02:15 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/e8d7d56a/38435078.mp3" length="1677888" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>105</itunes:duration>
      <itunes:summary>
        <![CDATA[August 01, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Digital Therapeutics for Alzheimer's and Parkinson's Diseases: Current Trends and Future Perspectives.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 31, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 31, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2aaac4e4-eece-41f8-ba99-d0a696f823c7</guid>
      <link>https://share.transistor.fm/s/9d8258bd</link>
      <description>
        <![CDATA[July 31, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: HoloDx: Knowledge- and Data-Driven Multimodal Diagnosis of Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 31, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: HoloDx: Knowledge- and Data-Driven Multimodal Diagnosis of Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 31 Jul 2025 16:02:12 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/9d8258bd/e4a33e00.mp3" length="1582848" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>99</itunes:duration>
      <itunes:summary>
        <![CDATA[July 31, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: HoloDx: Knowledge- and Data-Driven Multimodal Diagnosis of Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 29, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 29, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">bd28148a-9a08-4481-a645-221dd3f0c0de</guid>
      <link>https://share.transistor.fm/s/df946962</link>
      <description>
        <![CDATA[July 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Understanding the Insulin-Degrading Enzyme: A New Look at Alzheimer's Disease and Aβ Plaque Management.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Understanding the Insulin-Degrading Enzyme: A New Look at Alzheimer's Disease and Aβ Plaque Management.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 29 Jul 2025 16:02:12 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/df946962/2f89de71.mp3" length="1169856" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>74</itunes:duration>
      <itunes:summary>
        <![CDATA[July 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Understanding the Insulin-Degrading Enzyme: A New Look at Alzheimer's Disease and Aβ Plaque Management.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 28, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 28, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ba523060-10ad-43ea-b9e8-e0327c4a0fe5</guid>
      <link>https://share.transistor.fm/s/27ee169e</link>
      <description>
        <![CDATA[July 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Near-Infrared Fluorescent Probe for the Early Diagnosis of Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Near-Infrared Fluorescent Probe for the Early Diagnosis of Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 28 Jul 2025 16:02:13 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/27ee169e/a67d14b8.mp3" length="1738368" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>109</itunes:duration>
      <itunes:summary>
        <![CDATA[July 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Near-Infrared Fluorescent Probe for the Early Diagnosis of Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 27, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 27, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c9d67dd8-68e0-4507-8e11-d09a38a1b010</guid>
      <link>https://share.transistor.fm/s/e3692ce7</link>
      <description>
        <![CDATA[July 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 27 Jul 2025 16:02:13 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/e3692ce7/2a3d2d9f.mp3" length="1374336" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>86</itunes:duration>
      <itunes:summary>
        <![CDATA[July 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 26, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 26, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c5eeef1b-1e52-417d-a02e-5aede9640ec2</guid>
      <link>https://share.transistor.fm/s/27c10a40</link>
      <description>
        <![CDATA[July 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Understanding late-life depression: focus on inflammation.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Understanding late-life depression: focus on inflammation.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 26 Jul 2025 16:01:53 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/27c10a40/c9a60110.mp3" length="112320" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[July 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Understanding late-life depression: focus on inflammation.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 25, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 25, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">497457a8-caf3-4ce2-8aef-58535fb030a8</guid>
      <link>https://share.transistor.fm/s/82e466c9</link>
      <description>
        <![CDATA[July 25, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Development and validation of a model to predict the progression of Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 25, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Development and validation of a model to predict the progression of Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 25 Jul 2025 16:02:29 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/82e466c9/8c77453f.mp3" length="1545984" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>97</itunes:duration>
      <itunes:summary>
        <![CDATA[July 25, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Development and validation of a model to predict the progression of Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 24, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 24, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d982bb9a-a53c-42a2-a684-83c85cf6da49</guid>
      <link>https://share.transistor.fm/s/4a897a73</link>
      <description>
        <![CDATA[July 24, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Evolution of Alzheimer's Disease: From Mitochondria to Microglia.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 24, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Evolution of Alzheimer's Disease: From Mitochondria to Microglia.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 24 Jul 2025 16:02:14 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/4a897a73/8ff24a82.mp3" length="1512576" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>95</itunes:duration>
      <itunes:summary>
        <![CDATA[July 24, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Evolution of Alzheimer's Disease: From Mitochondria to Microglia.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 23, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 23, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">6f53b9c9-eeac-4f86-8629-93ca48416747</guid>
      <link>https://share.transistor.fm/s/f67a8636</link>
      <description>
        <![CDATA[July 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cell-type-directed network-correcting combination therapy for Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cell-type-directed network-correcting combination therapy for Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 23 Jul 2025 16:02:16 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/f67a8636/913cfeb2.mp3" length="1481472" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>93</itunes:duration>
      <itunes:summary>
        <![CDATA[July 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Cell-type-directed network-correcting combination therapy for Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 22, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 22, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b4ec80fe-2422-474c-b77b-551b938bbc29</guid>
      <link>https://share.transistor.fm/s/7b468dfb</link>
      <description>
        <![CDATA[July 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer's Disease and Its Potential as a Blood Biomarker for Early Diagnosis and Progression.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer's Disease and Its Potential as a Blood Biomarker for Early Diagnosis and Progression.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 22 Jul 2025 16:02:32 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/7b468dfb/329becda.mp3" length="2170368" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>136</itunes:duration>
      <itunes:summary>
        <![CDATA[July 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Role of Glial Fibrillary Acidic Protein in the Neuropathology of Alzheimer's Disease and Its Potential as a Blood Biomarker for Early Diagnosis and Progression.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 21, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 21, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c02812e2-68e6-497c-b031-3977d4fe54b9</guid>
      <link>https://share.transistor.fm/s/4ae6d31a</link>
      <description>
        <![CDATA[July 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Personalised regional modelling predicts tau progression in the human brain.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Personalised regional modelling predicts tau progression in the human brain.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 21 Jul 2025 16:02:49 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/4ae6d31a/78c97bea.mp3" length="1725696" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>108</itunes:duration>
      <itunes:summary>
        <![CDATA[July 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Personalised regional modelling predicts tau progression in the human brain.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 20, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 20, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">9ed4ce89-fd8f-4bf1-b10c-7c29d688c932</guid>
      <link>https://share.transistor.fm/s/50128ebf</link>
      <description>
        <![CDATA[July 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: TREM2 and LAG-3 in cancer and Alzheimer's disease immunotherapy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: TREM2 and LAG-3 in cancer and Alzheimer's disease immunotherapy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 20 Jul 2025 16:02:22 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/50128ebf/a95fd8f5.mp3" length="1670400" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>105</itunes:duration>
      <itunes:summary>
        <![CDATA[July 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: TREM2 and LAG-3 in cancer and Alzheimer's disease immunotherapy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 19, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 19, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">eac344e3-c733-4723-9e8d-67726cef1b99</guid>
      <link>https://share.transistor.fm/s/5fe592a0</link>
      <description>
        <![CDATA[July 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Comparison of two preprocessing methods for (18)F-Flortaucipir PET quantification in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Comparison of two preprocessing methods for (18)F-Flortaucipir PET quantification in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 19 Jul 2025 16:02:42 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/5fe592a0/9ffa40e7.mp3" length="2280384" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>143</itunes:duration>
      <itunes:summary>
        <![CDATA[July 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Comparison of two preprocessing methods for (18)F-Flortaucipir PET quantification in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 18, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 18, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">8366d2ac-3984-4e71-bae7-92f67e3f9077</guid>
      <link>https://share.transistor.fm/s/90dbd135</link>
      <description>
        <![CDATA[July 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Insights into the toxic effects of micro-nano-plastics on the human brain and their relationship with the onset of neurological diseases: a narrative review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Insights into the toxic effects of micro-nano-plastics on the human brain and their relationship with the onset of neurological diseases: a narrative review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 18 Jul 2025 16:02:59 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/90dbd135/6ba487b5.mp3" length="2344896" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>147</itunes:duration>
      <itunes:summary>
        <![CDATA[July 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Insights into the toxic effects of micro-nano-plastics on the human brain and their relationship with the onset of neurological diseases: a narrative review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 17, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 17, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">5001d448-e463-4040-8df8-59f48383d3e1</guid>
      <link>https://share.transistor.fm/s/3d666aa4</link>
      <description>
        <![CDATA[July 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Genetic insights into the association between inflammatory bowel disease and Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Genetic insights into the association between inflammatory bowel disease and Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 17 Jul 2025 16:02:48 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/3d666aa4/f77b3ae5.mp3" length="2267712" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>142</itunes:duration>
      <itunes:summary>
        <![CDATA[July 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Genetic insights into the association between inflammatory bowel disease and Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 16, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 16, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">84afa883-9afa-4364-8a82-060f15f67f2b</guid>
      <link>https://share.transistor.fm/s/abe29b73</link>
      <description>
        <![CDATA[July 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 16 Jul 2025 16:03:20 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/abe29b73/555ac58a.mp3" length="1933632" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>121</itunes:duration>
      <itunes:summary>
        <![CDATA[July 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Shared and disease-specific pathways in frontotemporal dementia and Alzheimer's and Parkinson's diseases.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 15, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 15, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ef483699-a966-4af7-96da-c87e04641a97</guid>
      <link>https://share.transistor.fm/s/9d67d590</link>
      <description>
        <![CDATA[July 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Ubiquitination in the Nervous System: From Molecular Mechanisms to Disease Implications.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Ubiquitination in the Nervous System: From Molecular Mechanisms to Disease Implications.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 15 Jul 2025 16:02:48 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/9d67d590/d72fb3c1.mp3" length="1554048" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>98</itunes:duration>
      <itunes:summary>
        <![CDATA[July 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Ubiquitination in the Nervous System: From Molecular Mechanisms to Disease Implications.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 14, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 14, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">ec0095fb-7ffb-4d3b-a47f-94801c2e528f</guid>
      <link>https://share.transistor.fm/s/40004cdc</link>
      <description>
        <![CDATA[July 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Targeting PBK with small-molecule 1-O-acetyl-4R,6S-britannilactone for the treatment of neuroinflammation.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Targeting PBK with small-molecule 1-O-acetyl-4R,6S-britannilactone for the treatment of neuroinflammation.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 14 Jul 2025 16:02:43 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/40004cdc/dfea3b31.mp3" length="1805760" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>113</itunes:duration>
      <itunes:summary>
        <![CDATA[July 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Targeting PBK with small-molecule 1-O-acetyl-4R,6S-britannilactone for the treatment of neuroinflammation.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 13, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 13, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">00affe05-bb8b-42ea-ac0d-f53ef3b86a4e</guid>
      <link>https://share.transistor.fm/s/f1365573</link>
      <description>
        <![CDATA[July 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Lipid mediated formation of antiparallel aggregates in cerebral amyloid angiopathy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Lipid mediated formation of antiparallel aggregates in cerebral amyloid angiopathy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 13 Jul 2025 16:02:43 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/f1365573/fea0a144.mp3" length="2095488" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>131</itunes:duration>
      <itunes:summary>
        <![CDATA[July 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Lipid mediated formation of antiparallel aggregates in cerebral amyloid angiopathy.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 12, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 12, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d3563786-b466-471a-9c9e-aa32e42e6738</guid>
      <link>https://share.transistor.fm/s/0a7e498e</link>
      <description>
        <![CDATA[July 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Gut-brain-immune interactions: exploring probiotics as a drug delivery platform for neurological disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Gut-brain-immune interactions: exploring probiotics as a drug delivery platform for neurological disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 12 Jul 2025 16:02:24 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/0a7e498e/0dec45ee.mp3" length="1711872" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>107</itunes:duration>
      <itunes:summary>
        <![CDATA[July 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Gut-brain-immune interactions: exploring probiotics as a drug delivery platform for neurological disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 11, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 11, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c72c7d34-46ba-4554-b59b-04ed85a58603</guid>
      <link>https://share.transistor.fm/s/19956041</link>
      <description>
        <![CDATA[July 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Rapid Fluorescence Lifetime Imaging through One-Dimensional Deep Learning Optimization.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Rapid Fluorescence Lifetime Imaging through One-Dimensional Deep Learning Optimization.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 11 Jul 2025 16:02:28 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/19956041/0496e213.mp3" length="1809792" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>114</itunes:duration>
      <itunes:summary>
        <![CDATA[July 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Rapid Fluorescence Lifetime Imaging through One-Dimensional Deep Learning Optimization.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 10, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 10, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">a390fe59-e92f-4878-b608-9ad15c07f84d</guid>
      <link>https://share.transistor.fm/s/81c28cdf</link>
      <description>
        <![CDATA[July 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: MAMSI: Integration of Multiassay Liquid Chromatography-Mass Spectrometry Metabolomics Data Using Multiview Machine Learning.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: MAMSI: Integration of Multiassay Liquid Chromatography-Mass Spectrometry Metabolomics Data Using Multiview Machine Learning.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 10 Jul 2025 16:02:29 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/81c28cdf/5fa674c1.mp3" length="2014272" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>126</itunes:duration>
      <itunes:summary>
        <![CDATA[July 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: MAMSI: Integration of Multiassay Liquid Chromatography-Mass Spectrometry Metabolomics Data Using Multiview Machine Learning.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 09, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 09, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">66525c26-1e8e-42c8-b5d5-bf9a994183af</guid>
      <link>https://share.transistor.fm/s/2579d8f9</link>
      <description>
        <![CDATA[July 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Exosome-Mediated Delivery of Amyloid Beta Modulators: A Potential Therapeutic Strategy for Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Exosome-Mediated Delivery of Amyloid Beta Modulators: A Potential Therapeutic Strategy for Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 09 Jul 2025 16:03:15 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/2579d8f9/d696a1d5.mp3" length="1636416" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>103</itunes:duration>
      <itunes:summary>
        <![CDATA[July 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Exosome-Mediated Delivery of Amyloid Beta Modulators: A Potential Therapeutic Strategy for Alzheimer's Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 06, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 06, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">bbbfb12c-3801-4fb2-8f6c-d844367cec43</guid>
      <link>https://share.transistor.fm/s/8f271e5a</link>
      <description>
        <![CDATA[July 06, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Therapeutic Potential of Adiponectin and Extracellular Vesicles for Promoting Improved Healthspan.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 06, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Therapeutic Potential of Adiponectin and Extracellular Vesicles for Promoting Improved Healthspan.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 06 Jul 2025 16:02:14 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/8f271e5a/56d31501.mp3" length="1657728" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>104</itunes:duration>
      <itunes:summary>
        <![CDATA[July 06, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Therapeutic Potential of Adiponectin and Extracellular Vesicles for Promoting Improved Healthspan.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 05, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 05, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">723cc9b3-ba52-4d5f-b8da-6f8590c405f8</guid>
      <link>https://share.transistor.fm/s/f382dcd7</link>
      <description>
        <![CDATA[July 05, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 05, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 05 Jul 2025 16:02:29 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/f382dcd7/8f85416b.mp3" length="1741824" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>109</itunes:duration>
      <itunes:summary>
        <![CDATA[July 05, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Intersection of circadian rhythms and the blood-brain barrier with drug efficacy and delivery in neurological disorders.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 04, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 04, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">86b3ec43-0cef-4979-bcea-eaa91aedd230</guid>
      <link>https://share.transistor.fm/s/5d3bdbae</link>
      <description>
        <![CDATA[July 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Mechanisms underlying the interplay between autophagy and the inflammasome in age-related diseases: implications for exercise immunology.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Mechanisms underlying the interplay between autophagy and the inflammasome in age-related diseases: implications for exercise immunology.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 04 Jul 2025 16:02:19 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/5d3bdbae/37927df9.mp3" length="1744128" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>110</itunes:duration>
      <itunes:summary>
        <![CDATA[July 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Mechanisms underlying the interplay between autophagy and the inflammasome in age-related diseases: implications for exercise immunology.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 03, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 03, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">9adc6b59-4803-48f7-9c2c-1906fa36902c</guid>
      <link>https://share.transistor.fm/s/ec65cda0</link>
      <description>
        <![CDATA[July 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Dementia Risk Due to Traumatic Brain Injury in Subtypes of Dementia in the Welsh Population.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Dementia Risk Due to Traumatic Brain Injury in Subtypes of Dementia in the Welsh Population.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 03 Jul 2025 16:02:23 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/ec65cda0/58aed63d.mp3" length="112320" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[July 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Dementia Risk Due to Traumatic Brain Injury in Subtypes of Dementia in the Welsh Population.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>July 01, 2025 - Alzheimer Research Update</title>
      <itunes:title>July 01, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2367e2a9-4893-4625-acb0-6103d2b3a698</guid>
      <link>https://share.transistor.fm/s/ef73e22c</link>
      <description>
        <![CDATA[July 01, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Role and Mechanism of Anti-ICOS mAb in Experimental Autoimmune Encephalomyelitis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[July 01, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Role and Mechanism of Anti-ICOS mAb in Experimental Autoimmune Encephalomyelitis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 01 Jul 2025 16:02:17 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/ef73e22c/dc29ae56.mp3" length="112320" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[July 01, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The Role and Mechanism of Anti-ICOS mAb in Experimental Autoimmune Encephalomyelitis.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 30, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 30, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e077d066-0a31-48fb-b5e0-56ea474f981f</guid>
      <link>https://share.transistor.fm/s/5e17a6a5</link>
      <description>
        <![CDATA[June 30, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 30, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 30 Jun 2025 16:02:30 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/5e17a6a5/1064760f.mp3" length="2007360" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>126</itunes:duration>
      <itunes:summary>
        <![CDATA[June 30, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 29, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 29, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c58e22f9-26a4-430e-bb33-609dd64e2d4a</guid>
      <link>https://share.transistor.fm/s/61fb3cf2</link>
      <description>
        <![CDATA[June 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 29 Jun 2025 16:02:01 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/61fb3cf2/fa9e6662.mp3" length="1879488" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>118</itunes:duration>
      <itunes:summary>
        <![CDATA[June 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 28, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 28, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">a156b8db-2497-450d-bd1b-772a33df7210</guid>
      <link>https://share.transistor.fm/s/a41be56f</link>
      <description>
        <![CDATA[June 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 28 Jun 2025 16:01:59 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/a41be56f/df1fc3fb.mp3" length="2122560" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>133</itunes:duration>
      <itunes:summary>
        <![CDATA[June 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 27, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 27, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">262d20d6-d529-4364-874c-9ec02b1a5eab</guid>
      <link>https://share.transistor.fm/s/ba164982</link>
      <description>
        <![CDATA[June 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 27 Jun 2025 16:02:37 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/ba164982/a513f67d.mp3" length="1987200" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>125</itunes:duration>
      <itunes:summary>
        <![CDATA[June 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and APOE Genotype in Alzheimer Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 26, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 26, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7087aa92-11f0-474e-b1f9-69632505d4df</guid>
      <link>https://share.transistor.fm/s/9588330e</link>
      <description>
        <![CDATA[June 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: SEL1L-HRD1-mediated ERAD in mammals.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: SEL1L-HRD1-mediated ERAD in mammals.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 26 Jun 2025 16:02:12 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/9588330e/9a759e11.mp3" length="1729728" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>109</itunes:duration>
      <itunes:summary>
        <![CDATA[June 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: SEL1L-HRD1-mediated ERAD in mammals.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 25, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 25, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7945e8c1-af84-4210-9725-5b22a6a59449</guid>
      <link>https://share.transistor.fm/s/3ad1403c</link>
      <description>
        <![CDATA[June 25, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Can Cognitive Reserve Offset APOE-Related Alzheimer's Risk? A Systematic Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 25, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Can Cognitive Reserve Offset APOE-Related Alzheimer's Risk? A Systematic Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 25 Jun 2025 16:02:15 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/3ad1403c/9da8856d.mp3" length="1702656" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>107</itunes:duration>
      <itunes:summary>
        <![CDATA[June 25, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Can Cognitive Reserve Offset APOE-Related Alzheimer's Risk? A Systematic Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 24, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 24, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">a9a45d86-9a86-4aad-9dff-e1ef828b43f0</guid>
      <link>https://share.transistor.fm/s/f4251087</link>
      <description>
        <![CDATA[June 24, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Can Cognitive Reserve Offset APOE-Related Alzheimer's Risk? A Systematic Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 24, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Can Cognitive Reserve Offset APOE-Related Alzheimer's Risk? A Systematic Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 24 Jun 2025 16:02:11 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/f4251087/a81e4718.mp3" length="1526976" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>96</itunes:duration>
      <itunes:summary>
        <![CDATA[June 24, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Can Cognitive Reserve Offset APOE-Related Alzheimer's Risk? A Systematic Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 23, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 23, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">3afff6d2-7c5b-4be9-8ee3-e87318464974</guid>
      <link>https://share.transistor.fm/s/6180134c</link>
      <description>
        <![CDATA[June 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Advancements and challenges in using AI for biomarker detection in early Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Advancements and challenges in using AI for biomarker detection in early Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 23 Jun 2025 16:01:59 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/6180134c/7c1c986a.mp3" length="1585152" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>100</itunes:duration>
      <itunes:summary>
        <![CDATA[June 23, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Advancements and challenges in using AI for biomarker detection in early Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 22, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 22, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">fc636b64-e545-49c5-a454-eb900d2b5e5c</guid>
      <link>https://share.transistor.fm/s/bc594523</link>
      <description>
        <![CDATA[June 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Extracellular matrix glycation epigenetically regulates brain aging and neurodegeneration in the in vitro aged neurovascular model.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Extracellular matrix glycation epigenetically regulates brain aging and neurodegeneration in the in vitro aged neurovascular model.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 22 Jun 2025 16:02:06 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/bc594523/a43cb239.mp3" length="1630656" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>102</itunes:duration>
      <itunes:summary>
        <![CDATA[June 22, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Extracellular matrix glycation epigenetically regulates brain aging and neurodegeneration in the in vitro aged neurovascular model.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 21, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 21, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e030b703-433a-4258-8471-2cbcc479aed5</guid>
      <link>https://share.transistor.fm/s/e1589c49</link>
      <description>
        <![CDATA[June 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Camellia oleifera oil: unveiling health benefits and exploring novel applications.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Camellia oleifera oil: unveiling health benefits and exploring novel applications.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 21 Jun 2025 16:02:10 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/e1589c49/1a0d9d7f.mp3" length="2289024" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>144</itunes:duration>
      <itunes:summary>
        <![CDATA[June 21, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Camellia oleifera oil: unveiling health benefits and exploring novel applications.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 20, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 20, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">1bdeee10-ba84-4760-bf4f-8ff493dab61e</guid>
      <link>https://share.transistor.fm/s/097b58f6</link>
      <description>
        <![CDATA[June 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 20 Jun 2025 16:02:24 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/097b58f6/da455ca7.mp3" length="1950336" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>122</itunes:duration>
      <itunes:summary>
        <![CDATA[June 20, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Decoding the Clinical Features that Associate with Progression, Causes, and Outcomes in Patients with Suspected Rapidly Progressive Dementia.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 19, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 19, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">82a24ed8-507e-4d7e-a0e4-4b2a1b452d8a</guid>
      <link>https://share.transistor.fm/s/7aa0ac2f</link>
      <description>
        <![CDATA[June 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The olfactory epithelium: a critical gateway for pathological tau propagation and a target for mitigating tauopathy in the central nervous system.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The olfactory epithelium: a critical gateway for pathological tau propagation and a target for mitigating tauopathy in the central nervous system.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 19 Jun 2025 16:02:24 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/7aa0ac2f/c71f4ac2.mp3" length="1945728" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>122</itunes:duration>
      <itunes:summary>
        <![CDATA[June 19, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The olfactory epithelium: a critical gateway for pathological tau propagation and a target for mitigating tauopathy in the central nervous system.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 18, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 18, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b7100f55-3d40-4643-b972-d18f9ba8ebbb</guid>
      <link>https://share.transistor.fm/s/51085868</link>
      <description>
        <![CDATA[June 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Progranulin function and regulation in the CNS.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Progranulin function and regulation in the CNS.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 18 Jun 2025 16:02:01 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/51085868/fbc35e9b.mp3" length="1633536" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>103</itunes:duration>
      <itunes:summary>
        <![CDATA[June 18, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Progranulin function and regulation in the CNS.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 17, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 17, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">9b8da645-43ab-4997-80f1-19b5e5c017f3</guid>
      <link>https://share.transistor.fm/s/ada01ba9</link>
      <description>
        <![CDATA[June 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Effectiveness of Community-Based Health Education on Modifiable Risk Factors for Alzheimer's Disease among Older Adults: A Scoping Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Effectiveness of Community-Based Health Education on Modifiable Risk Factors for Alzheimer's Disease among Older Adults: A Scoping Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 17 Jun 2025 16:02:29 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/ada01ba9/f48a3130.mp3" length="1976256" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>124</itunes:duration>
      <itunes:summary>
        <![CDATA[June 17, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Effectiveness of Community-Based Health Education on Modifiable Risk Factors for Alzheimer's Disease among Older Adults: A Scoping Review.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 16, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 16, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">f8782c41-d2aa-4151-bcd4-4e5997433eca</guid>
      <link>https://share.transistor.fm/s/44a771b3</link>
      <description>
        <![CDATA[June 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Clinical and Cognitive Profiles of Individuals with Alzheimer's Disease and Comorbid Seizures.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Clinical and Cognitive Profiles of Individuals with Alzheimer's Disease and Comorbid Seizures.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 16 Jun 2025 16:02:19 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/44a771b3/a64fefd4.mp3" length="1683072" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>106</itunes:duration>
      <itunes:summary>
        <![CDATA[June 16, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Clinical and Cognitive Profiles of Individuals with Alzheimer's Disease and Comorbid Seizures.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 15, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 15, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b973bfd3-73e6-48e2-a932-c9014f697710</guid>
      <link>https://share.transistor.fm/s/d3629e81</link>
      <description>
        <![CDATA[June 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Non-canonical roles of mitotic proteins in cortical neurons.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Non-canonical roles of mitotic proteins in cortical neurons.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 15 Jun 2025 16:02:16 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/d3629e81/6ae58a8a.mp3" length="1607616" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>101</itunes:duration>
      <itunes:summary>
        <![CDATA[June 15, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Non-canonical roles of mitotic proteins in cortical neurons.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 14, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 14, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">43f19a48-aa15-40e7-96fb-862f3fc5f00c</guid>
      <link>https://share.transistor.fm/s/1aed89a5</link>
      <description>
        <![CDATA[June 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Myelin-axon interface vulnerability in Alzheimer's disease revealed by subcellular proteomics and imaging of human and mouse brain.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Myelin-axon interface vulnerability in Alzheimer's disease revealed by subcellular proteomics and imaging of human and mouse brain.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 14 Jun 2025 16:02:20 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/1aed89a5/aab6957d.mp3" length="1858176" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>117</itunes:duration>
      <itunes:summary>
        <![CDATA[June 14, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Myelin-axon interface vulnerability in Alzheimer's disease revealed by subcellular proteomics and imaging of human and mouse brain.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 13, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 13, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">150bedf3-8af0-4de4-8e88-46ea655aa8ba</guid>
      <link>https://share.transistor.fm/s/e087ff0b</link>
      <description>
        <![CDATA[June 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Antiamyloid treatment for dementia: concerns outweigh hopes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Antiamyloid treatment for dementia: concerns outweigh hopes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 13 Jun 2025 16:02:16 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/e087ff0b/083de46b.mp3" length="1413504" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>89</itunes:duration>
      <itunes:summary>
        <![CDATA[June 13, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Antiamyloid treatment for dementia: concerns outweigh hopes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 12, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 12, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">b244a9b8-4923-4b43-a8bb-310a4333185e</guid>
      <link>https://share.transistor.fm/s/1c568f2b</link>
      <description>
        <![CDATA[June 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The role of the oral microbiome, host response, and periodontal disease treatment in Alzheimer's disease: A primer.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The role of the oral microbiome, host response, and periodontal disease treatment in Alzheimer's disease: A primer.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 12 Jun 2025 16:02:25 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/1c568f2b/b2be8f4b.mp3" length="1805760" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>113</itunes:duration>
      <itunes:summary>
        <![CDATA[June 12, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The role of the oral microbiome, host response, and periodontal disease treatment in Alzheimer's disease: A primer.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 11, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 11, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d5a6dd73-989e-449c-ba91-8de251d6bbe0</guid>
      <link>https://share.transistor.fm/s/ae3d4704</link>
      <description>
        <![CDATA[June 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The role of the oral microbiome, host response, and periodontal disease treatment in Alzheimer's disease: A primer.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The role of the oral microbiome, host response, and periodontal disease treatment in Alzheimer's disease: A primer.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 11 Jun 2025 16:02:33 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/ae3d4704/0343b5c9.mp3" length="1886400" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>118</itunes:duration>
      <itunes:summary>
        <![CDATA[June 11, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: The role of the oral microbiome, host response, and periodontal disease treatment in Alzheimer's disease: A primer.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 10, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 10, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2bcbc63d-827e-480c-8266-b5a8d5411c60</guid>
      <link>https://share.transistor.fm/s/0f26311c</link>
      <description>
        <![CDATA[June 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Perineural Invasion Exhibits Traits of Neurodegeneration.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Perineural Invasion Exhibits Traits of Neurodegeneration.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 10 Jun 2025 16:02:22 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/0f26311c/c4c95c0d.mp3" length="112896" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>8</itunes:duration>
      <itunes:summary>
        <![CDATA[June 10, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Perineural Invasion Exhibits Traits of Neurodegeneration.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 09, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 09, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7093c8b2-0cf8-4811-b5b6-29e60a214dcd</guid>
      <link>https://share.transistor.fm/s/0c3df381</link>
      <description>
        <![CDATA[June 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Plasma NfL, GFAP and pTau181 in patients with Isolated REM Sleep Behaviour Disorder.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Plasma NfL, GFAP and pTau181 in patients with Isolated REM Sleep Behaviour Disorder.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 09 Jun 2025 16:02:15 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/0c3df381/fbf4210a.mp3" length="1995840" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>125</itunes:duration>
      <itunes:summary>
        <![CDATA[June 09, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Plasma NfL, GFAP and pTau181 in patients with Isolated REM Sleep Behaviour Disorder.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 08, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 08, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">c7d7e042-a349-4e87-9cb1-468fa1a7ec23</guid>
      <link>https://share.transistor.fm/s/0e46a135</link>
      <description>
        <![CDATA[June 08, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Molecular signatures of regional vulnerability to tauopathy in excitatory cortical neurons.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 08, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Molecular signatures of regional vulnerability to tauopathy in excitatory cortical neurons.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 08 Jun 2025 16:02:17 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/0e46a135/77699ae7.mp3" length="1680192" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>106</itunes:duration>
      <itunes:summary>
        <![CDATA[June 08, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Molecular signatures of regional vulnerability to tauopathy in excitatory cortical neurons.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 07, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 07, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">45fa2a8a-cef9-4a61-8af2-d995241438f2</guid>
      <link>https://share.transistor.fm/s/cc143e9b</link>
      <description>
        <![CDATA[June 07, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Targeting FSH for osteoporosis, obesity, and Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 07, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Targeting FSH for osteoporosis, obesity, and Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 07 Jun 2025 16:02:07 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/cc143e9b/787603fb.mp3" length="2064960" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>130</itunes:duration>
      <itunes:summary>
        <![CDATA[June 07, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Targeting FSH for osteoporosis, obesity, and Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 06, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 06, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e4fb930c-053d-45fa-9eb9-468dd0a725dd</guid>
      <link>https://share.transistor.fm/s/9fb8f383</link>
      <description>
        <![CDATA[June 06, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Analysis of the splicing landscape of the frontal cortex in FTLD-TDP reveals subtype specific patterns and cryptic splicing.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 06, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Analysis of the splicing landscape of the frontal cortex in FTLD-TDP reveals subtype specific patterns and cryptic splicing.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 06 Jun 2025 16:02:18 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/9fb8f383/77d8dc2c.mp3" length="2262528" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>142</itunes:duration>
      <itunes:summary>
        <![CDATA[June 06, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Analysis of the splicing landscape of the frontal cortex in FTLD-TDP reveals subtype specific patterns and cryptic splicing.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 05, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 05, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">7444790b-8c19-4a5d-9d4d-ff4d0da577f2</guid>
      <link>https://share.transistor.fm/s/3cf59503</link>
      <description>
        <![CDATA[June 05, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Glucose metabolism in hyper-connected regions predicts neurodegeneration and speed of conversion in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 05, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Glucose metabolism in hyper-connected regions predicts neurodegeneration and speed of conversion in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 05 Jun 2025 16:02:26 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/3cf59503/df1abc2a.mp3" length="1632384" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>103</itunes:duration>
      <itunes:summary>
        <![CDATA[June 05, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Glucose metabolism in hyper-connected regions predicts neurodegeneration and speed of conversion in Alzheimer's disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 04, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 04, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">20f2b972-f31f-4d29-9edb-e322613d7649</guid>
      <link>https://share.transistor.fm/s/d3aa7cf7</link>
      <description>
        <![CDATA[June 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: SEW2871 Attenuates Blood-Brain Barrier Damage and Neuropathological Outcomes Related to Cerebral Small Vessel Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: SEW2871 Attenuates Blood-Brain Barrier Damage and Neuropathological Outcomes Related to Cerebral Small Vessel Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 04 Jun 2025 16:02:14 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/d3aa7cf7/0f61c5b7.mp3" length="2054016" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>129</itunes:duration>
      <itunes:summary>
        <![CDATA[June 04, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: SEW2871 Attenuates Blood-Brain Barrier Damage and Neuropathological Outcomes Related to Cerebral Small Vessel Disease.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 03, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 03, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">d5232813-61cc-43b1-b141-15e6cced4dc3</guid>
      <link>https://share.transistor.fm/s/90c38f21</link>
      <description>
        <![CDATA[June 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Gastrointestinal exposure to silica nanoparticles induced Alzheimer's disease-like neurotoxicity in mice relying on gut microbiota and modulation through TLR4/NF-κB and HDAC.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Gastrointestinal exposure to silica nanoparticles induced Alzheimer's disease-like neurotoxicity in mice relying on gut microbiota and modulation through TLR4/NF-κB and HDAC.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 03 Jun 2025 16:02:12 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/90c38f21/2c5b5d27.mp3" length="2025216" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>127</itunes:duration>
      <itunes:summary>
        <![CDATA[June 03, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Gastrointestinal exposure to silica nanoparticles induced Alzheimer's disease-like neurotoxicity in mice relying on gut microbiota and modulation through TLR4/NF-κB and HDAC.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 02, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 02, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">923a1ad7-5276-4ad5-8b91-17a0f4200790</guid>
      <link>https://share.transistor.fm/s/c5d4c4c1</link>
      <description>
        <![CDATA[June 02, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: APOE4 reshapes the lipid droplet proteome and modulates microglial inflammatory responses.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 02, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: APOE4 reshapes the lipid droplet proteome and modulates microglial inflammatory responses.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 02 Jun 2025 16:02:59 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/c5d4c4c1/53130962.mp3" length="2331072" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>146</itunes:duration>
      <itunes:summary>
        <![CDATA[June 02, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: APOE4 reshapes the lipid droplet proteome and modulates microglial inflammatory responses.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>June 01, 2025 - Alzheimer Research Update</title>
      <itunes:title>June 01, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">15569abc-bf2b-4dd4-b4a7-1a9288f2f2d9</guid>
      <link>https://share.transistor.fm/s/983521f5</link>
      <description>
        <![CDATA[June 01, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Probing new 3-hydrazinyl indole phenacetamide derivatives as multitarget anti-Alzheimer: Synthesis, in vivo, in vitro, and in silico studies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[June 01, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Probing new 3-hydrazinyl indole phenacetamide derivatives as multitarget anti-Alzheimer: Synthesis, in vivo, in vitro, and in silico studies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sun, 01 Jun 2025 16:02:57 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/983521f5/af4c92e6.mp3" length="1622016" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>102</itunes:duration>
      <itunes:summary>
        <![CDATA[June 01, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Probing new 3-hydrazinyl indole phenacetamide derivatives as multitarget anti-Alzheimer: Synthesis, in vivo, in vitro, and in silico studies.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 31, 2025 - Alzheimer Research Update</title>
      <itunes:title>May 31, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">cd3a92c6-05eb-4e97-8915-c104615b29bc</guid>
      <link>https://share.transistor.fm/s/1b41c31c</link>
      <description>
        <![CDATA[May 31, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 31, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Sat, 31 May 2025 16:01:09 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/1b41c31c/7bab25fb.mp3" length="2126592" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>133</itunes:duration>
      <itunes:summary>
        <![CDATA[May 31, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: SARS-CoV-2 infection of human cortical cells is influenced by the interaction between aneuploidy and biological sex: insights from a Down syndrome in vitro model.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 30, 2025 - Alzheimer Research Update</title>
      <itunes:title>May 30, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">bceb8a83-3285-45ce-b453-424000af0e60</guid>
      <link>https://share.transistor.fm/s/4e58d9b2</link>
      <description>
        <![CDATA[May 30, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Association of Blood Lipoprotein Levels With Incident Alzheimer Disease in Community-Dwelling Individuals: The Framingham Heart Study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 30, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Association of Blood Lipoprotein Levels With Incident Alzheimer Disease in Community-Dwelling Individuals: The Framingham Heart Study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Fri, 30 May 2025 16:01:05 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/4e58d9b2/538489d6.mp3" length="2893824" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>181</itunes:duration>
      <itunes:summary>
        <![CDATA[May 30, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Association of Blood Lipoprotein Levels With Incident Alzheimer Disease in Community-Dwelling Individuals: The Framingham Heart Study.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 29, 2025 - Alzheimer Research Update</title>
      <itunes:title>May 29, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">60500e63-28eb-4fbe-bdb7-d20d04e23738</guid>
      <link>https://share.transistor.fm/s/9cd66fe0</link>
      <description>
        <![CDATA[May 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Association of microplastics in human cerebrospinal fluid with Alzheimer's disease-related changes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Association of microplastics in human cerebrospinal fluid with Alzheimer's disease-related changes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Thu, 29 May 2025 16:01:15 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/9cd66fe0/1cccf54d.mp3" length="2423232" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>152</itunes:duration>
      <itunes:summary>
        <![CDATA[May 29, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Association of microplastics in human cerebrospinal fluid with Alzheimer's disease-related changes.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 28, 2025 - Alzheimer Research Update</title>
      <itunes:title>May 28, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">2dd5d4f8-b0dc-4258-8396-03a0f5df25f2</guid>
      <link>https://share.transistor.fm/s/e314799b</link>
      <description>
        <![CDATA[May 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Nanoimmunomodulation of the Aβ-STING feedback machinery in microglia for Alzheimer's disease treatment.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Nanoimmunomodulation of the Aβ-STING feedback machinery in microglia for Alzheimer's disease treatment.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Wed, 28 May 2025 16:01:02 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/e314799b/3c5a79ce.mp3" length="1953792" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>123</itunes:duration>
      <itunes:summary>
        <![CDATA[May 28, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Nanoimmunomodulation of the Aβ-STING feedback machinery in microglia for Alzheimer's disease treatment.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 27, 2025 - Alzheimer Research Update</title>
      <itunes:title>May 27, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">e85747c2-1f0a-4952-8739-d741f6fe241b</guid>
      <link>https://share.transistor.fm/s/392bd5c6</link>
      <description>
        <![CDATA[May 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Accumulation of GSK-3β in Interneurons Impairs Adult Hippocampal Neurogenesis by Inhibiting GABAergic Transmission.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Accumulation of GSK-3β in Interneurons Impairs Adult Hippocampal Neurogenesis by Inhibiting GABAergic Transmission.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Tue, 27 May 2025 01:01:22 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/392bd5c6/2050cf6f.mp3" length="2056896" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>129</itunes:duration>
      <itunes:summary>
        <![CDATA[May 27, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Accumulation of GSK-3β in Interneurons Impairs Adult Hippocampal Neurogenesis by Inhibiting GABAergic Transmission.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
    <item>
      <title>May 26, 2025 - Alzheimer Research Update</title>
      <itunes:title>May 26, 2025 - Alzheimer Research Update</itunes:title>
      <itunes:episodeType>full</itunes:episodeType>
      <guid isPermaLink="false">f9f12f11-9c1e-49ae-a11a-5e43f7bd31f9</guid>
      <link>https://share.transistor.fm/s/b9bda42a</link>
      <description>
        <![CDATA[May 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Accumulation of GSK-3β in Interneurons Impairs Adult Hippocampal Neurogenesis by Inhibiting GABAergic Transmission.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </description>
      <content:encoded>
        <![CDATA[May 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Accumulation of GSK-3β in Interneurons Impairs Adult Hippocampal Neurogenesis by Inhibiting GABAergic Transmission.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </content:encoded>
      <pubDate>Mon, 26 May 2025 11:57:07 -0700</pubDate>
      <author>meng</author>
      <enclosure url="https://media.transistor.fm/b9bda42a/13f7d6fb.mp3" length="2279808" type="audio/mpeg"/>
      <itunes:author>meng</itunes:author>
      <itunes:duration>143</itunes:duration>
      <itunes:summary>
        <![CDATA[May 26, 2025 - Latest Alzheimer Research Update

Today's episode covers the most significant research finding in alzheimer from leading medical journals. Our expert hosts Ava and Andrew discuss the breakthrough study with the highest impact factor published yesterday on PubMed, including clinical implications and emerging therapeutic approaches.

Featured Paper: Accumulation of GSK-3β in Interneurons Impairs Adult Hippocampal Neurogenesis by Inhibiting GABAergic Transmission.

Key topics include:
• The highest impact factor research published yesterday on PubMed
• Clinical implications and institutional insights
• Practical implications for medical professionals
• Emerging therapeutic targets and treatment approaches

Brought to you by www.labcat.ai - AI-powered research tools to boost your efficiency 100x. Visit www.labcat.ai to learn more.

Perfect for medical professionals, researchers, and anyone interested in staying current with alzheimer research developments.

#MedicalResearch #Alzheimer #PubMed #Research #Medicine #Healthcare]]>
      </itunes:summary>
      <itunes:keywords>alzheimer,alzheimers,dementia,medical,research,pubmed</itunes:keywords>
      <itunes:explicit>No</itunes:explicit>
    </item>
  </channel>
</rss>
